Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40760888	s-iglc-v	— (—)	8537	28208	100.00%	Distribution not available
40760888	s-iglc-v-2	— (—)	9	10	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other heart diseases

850

1162

4.89

322.19

3.6

3.5

—

Persons encountering health services for specific procedures and health care

2229

5285

2.58

320.69

3.7

3.1

—

Infections, IBD-co-morbidities

445

342

9.71

314.75

5.5

4.1

—

Nutritional anaemias

1422

4642

3.06

313.14

2.3

3.4

—

Other anaemias

2073

3802

5.62

307.65

3.1

3.3

—

Implicit bacterial Sepsis

1470

3473

3.95

307.65

3.4

3.0

—

Explicit Sepsis

1416

3613

3.83

307.65

4.3

3.1

—

2131

4188

3.16

307.65

4.7

2.5

—

Heart failure and antihypertensive medication

844

872

6.70

307.65

3.0

4.5

—

Multiple myeloma, including Hilmo

959

339

62.23

307.65

16.8

1.5

—

Bacterial infection, other or unspecified

1994

4184

4.23

307.65

4.2

3.0

—

Renal failure

2860

3497

8.10

307.65

3.0

3.4

—

Pneumonias (Asthma/COPD co-morbidities)

2349

5349

3.02

307.65

4.6

2.8

—

Acute renal failure

1188

1689

7.85

307.65

3.6

3.3

—

Bacterial infection, other or unspecified

1907

4060

4.29

307.65

4.3

3.0

—

Pneumonia, organism unspecified

2221

5120

3.12

307.65

4.5

2.7

—

Care involving dialysis

580

544

12.74

307.65

2.9

3.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

2591

4325

3.44

307.65

2.9

2.0

—

Second line medication for Crohn's disease

1684

4575

3.83

307.65

8.6

2.1

—

Other bacterial diseases

2653

4917

3.53

307.65

3.7

3.0

—

Acute tubulo-interstitial nephritis

1444

3887

3.30

307.65

2.7

3.6

—

Heart failure, strict

1870

4333

3.18

307.65

3.0

3.5

—

Renal tubulo-interstitial diseases

3280

4514

5.71

307.65

3.0

3.6

—

Glomerular disorders in diseases classified elsewhere

696

895

8.89

307.65

3.4

3.7

—

Inflammatory bowel disease treatment related agents

2558

5229

2.80

307.65

2.8

3.6

—

ILD medications

2786

4330

3.58

307.65

4.5

2.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

691

665

12.91

307.65

2.9

3.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

1681

2144

9.07

307.65

10.7

1.5

—

Metabolic disorders

2143

4816

2.78

307.65

3.4

3.3

—

Chronic kidney disease

2222

2512

10.02

307.65

2.5

3.3

—

Heart failure, not strict

2433

4061

4.26

307.65

3.4

3.5

—

Polyarthropathies

1858

3433

3.65

307.65

3.2

3.7

—

Unspecified kidney failure

599

758

8.99

307.65

3.2

3.4

—

Implicit Sepsis

2221

4949

3.39

307.65

3.4

3.2

—

Secondary hypertension

366

328

12.13

307.65

2.1

3.3

—

Anaemias

688

223

21.12

307.65

3.3

1.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2131

4188

3.16

307.65

4.7

2.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2200

4925

3.25

307.65

3.3

3.2

—

Oral corticosteroids

2573

5213

3.00

307.65

2.8

3.6

—

Transplanted organ and tissue status

527

604

9.86

307.65

7.5

3.7

—

Implicit bacterial Sepsis

1552

3680

3.83

307.65

3.4

3.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3562

4601

5.61

307.65

3.2

3.4

—

Osteopathies and chondropathies

1668

4649

3.48

307.65

4.0

3.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2151

4799

3.17

307.65

3.3

3.2

—

Other and unspecified anaemias

2065

3777

5.65

307.65

3.2

3.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2302

5450

2.95

307.65

4.5

2.9

—

Glomerular diseases

1048

1468

8.05

307.65

3.1

3.6

—

Abnormal findings on examination of blood, without diagnosis

1519

4339

3.36

307.65

3.2

3.4

—

Osteoporosis

1001

2310

4.33

307.65

2.9

3.3

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

993

350

59.65

307.65

6.5

1.3

—

Extracorporeal dialysis

419

472

10.59

307.65

3.2

3.7

—

L04AX Other immunosuppressants

1664

4478

3.87

307.65

8.7

2.1

—

Other septicaemia

1230

3231

3.84

307.65

3.9

3.0

—

Gout

1031

2306

4.17

307.65

4.3

3.7

—

Multiple myeloma and malignant plasma cell neoplasms

980

401

52.80

307.65

16.6

1.8

—

General symptoms and signs

2131

3883

2.80

307.65

3.4

3.2

—

Heart failure,strict

1740

3237

3.98

307.65

3.1

3.5

—

Implicit Sepsis

2174

4854

3.50

307.65

3.4

3.2

—

All kidney diseases

3266

4341

5.37

307.65

3.2

3.6

—

Other bacterial diseases

2756

5093

3.77

307.65

4.0

3.0

—

All pneumoniae

2357

5362

3.01

307.65

4.6

2.8

—

Liquid cancers, helper endpoint

2621

2659

9.79

307.65

7.9

1.3

—

Glomerulonephritis

503

726

7.74

307.65

2.8

3.7

—

Influenza and pneumonia

2400

5239

2.98

307.65

4.8

2.7

—

Fever of other and unknown origin

1764

3518

4.65

307.65

5.0

3.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

623

201

81.23

307.65

17.4

1.5

—

All-cause Heart Failure

1820

4273

3.14

307.65

3.0

3.5

—

All chronic kidney diseases

2934

3172

8.28

307.65

2.8

3.5

—

Dialysis, with operation codes

798

776

11.90

307.65

3.4

3.9

—

Aplastic and other anaemias

2190

3989

5.54

307.65

3.1

3.3

—

Multiple myeloma

623

201

81.23

307.65

17.4

1.5

—

Septicaemia

1390

3472

3.93

307.65

4.3

3.0

—

Bacterial Sepsis

1652

3746

3.96

307.65

3.7

3.1

—

Nephropathy related operations

747

962

8.93

307.65

3.4

3.7

—

Malaise and fatigue

1307

3181

3.41

307.65

2.8

3.3

—

ILD medications: immunosuppressive drugs

2143

3753

5.56

307.65

7.2

2.0

—

First line medication for Crohn's disease

2565

4177

3.40

307.65

4.7

1.8

—

Disorders of calcium metabolism

375

443

9.71

299.45

4.4

3.7

—

Iron deficiency anaemia

1243

3961

3.22

298.37

2.3

3.5

—

Gout, FINNGEN

1031

3012

3.61

293.59

4.3

3.3

—

Disorders of mineral metabolism

409

565

8.04

284.82

4.1

3.6

—

Hypertensive diseases (excluding secondary)

872

1172

4.41

280.93

2.9

3.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1995

5258

2.52

280.39

3.7

3.1

—

Oxycodone

1104

3112

3.33

275.81

6.9

2.7

—

L04AD Calcineurin inhibitors

435

663

7.15

275.66

3.2

4.1

—

Diabetic nephropathy, excluding more controls

620

1027

5.41

274.85

1.9

2.9

—

Erysipelas

1598

4589

2.72

271.99

2.7

3.0

—

Systemic connective tissue disorders

1036

3206

3.37

269.16

2.3

3.5

—

Type 2 diabetes, wide definition

1862

4782

2.55

266.34

2.4

3.9

—

Other and unspecified iron deficiency

992

3025

3.42

263.50

2.2

3.4

—

Other disorders of fluid, electrolyte and acid-base balance

954

2706

3.51

260.40

2.9

3.3

—

Other heart diseases, wide

1668

3903

2.66

257.32

3.4

—

Autoimmune diseases excluding thyroid diseases

2110

4868

2.41

257.05

2.5

3.7

—

Hypertension, essential

1434

2863

2.89

251.00

2.9

4.0

—

Other systemic involvement of connective tissue (FG)

728

1843

4.07

249.81

2.2

3.8

—

Tramadol

1605

3776

2.66

248.07

3.4

2.7

—

Autoimmune diseases excluding thyroid diseases, strict definition

2035

4716

2.40

247.71

2.6

3.6

—

Dyspnoea

1956

6256

2.36

246.03

3.3

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

140

80.15

244.99

7.0

1.3

—

Hypertensive diseases

1428

2880

2.85

244.06

2.8

4.0

—

Hypertension

1427

2880

2.85

243.49

2.8

4.0

—

Any gastric operation

1257

2055

3.11

239.51

3.2

2.7

—

GASTRO-related operations

1257

2055

3.11

239.51

3.2

2.7

—

Nephrotic syndrome

223

174

15.54

238.77

2.8

4.1

—

Heart failure and coronary heart disease

1295

3295

2.90

238.35

2.7

3.6

—

Implicit viral Sepsis

649

1598

4.28

237.32

4.8

3.1

—

Viral Sepsis

649

1599

4.28

237.11

4.8

3.1

—

Implicit viral Sepsis

833

2450

3.55

234.51

4.4

3.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

575

808

5.11

232.28

2.9

3.6

—

Certain infectious and parasitic diseases

1764

3583

2.50

227.83

3.5

2.6

—

Heart failure and bmi 25plus

1044

2300

3.20

223.88

2.9

3.9

—

Asthma, unspecified (mode), excluding more controls

966

2276

3.24

223.25

2.6

—

Finngen Rheumatological endpoints

1727

4097

2.44

219.09

2.8

3.7

—

Erysipelas

1272

4318

2.67

216.28

2.9

3.0

—

Amyloidosis

206

171

15.65

214.65

10.3

3.9

—

Hypercalcemia

282

362

9.23

212.05

4.5

4.0

—

L04AA Selective immunosuppressants

628

1637

4.02

211.91

2.4

3.5

—

COPD/asthma related infections

1912

4188

2.32

210.58

4.3

2.5

—

COPD/asthma/ILD related infections

1912

4188

2.32

210.58

4.3

2.5

—

Abnormalities of breathing

1666

4063

2.42

209.86

3.2

3.3

—

Insulin medication

1392

4754

2.52

208.26

2.6

3.7

—

Other diseases of blood and blood-forming organs, wide

693

1961

3.72

208.11

3.5

3.4

—

Hypertensive heart and/or renal disease

775

1669

3.62

207.12

2.4

4.1

—

Amyloidosis, other/unspecified

187

143

17.78

205.78

11.1

4.2

—

Malignant immunoproliferative diseases

149

33.13

204.79

6.8

3.9

—

Kidney transplant status

256

303

9.51

203.51

2.2

4.6

—

Cardiovascular diseases (excluding rheumatic etc)

794

1261

3.67

203.26

3.3

3.4

—

Oedema, not elsewhere classified

788

2432

3.30

199.65

3.1

3.3

—

Atrial fibrillation and flutter

604

935

4.30

196.73

3.6

—

Non-ischemic cardiomyopathy

885

2348

3.16

196.11

3.4

3.6

—

Disorders resulting from impaired renal tubular function

237

270

10.43

196.09

1.7

3.7

—

Valvular heart disease excluding rheumatic fever

1081

2866

2.80

190.61

3.4

3.5

—

Preparatory care for dialysis

264

356

8.67

189.98

2.2

4.2

—

Diabetic nephropathy

624

1737

3.83

189.83

1.8

2.8

—

Asthma, unspecified (mode)

1010

2715

2.86

188.80

2.6

—

Non-rheumatic valve diseases

1075

2861

2.79

187.93

3.4

3.5

—

Dental caries

660

1862

3.53

184.30

5.6

2.8

—

Osteoporosis with pathological fracture (FG)

316

530

6.57

183.20

2.3

3.6

—

Diabetes mellitus

1873

5138

2.16

182.91

2.4

3.8

—

Diabetes, varying definitions

1869

5142

2.16

182.71

2.5

3.8

—

Other arthritis (FG)

709

2220

3.29

179.92

2.8

3.7

—

Opioids

1663

3842

2.28

178.23

3.5

2.7

—

Disorders of other endocrine glands

972

3589

2.74

176.92

2.9

3.2

—

Other systemic involvement of connective tissue

745

2449

3.16

175.01

2.3

3.4

—

Codeine

1592

3830

2.29

174.80

3.2

2.7

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1377

4810

2.36

174.72

2.4

3.8

—

Caries of dentine

598

1669

3.62

173.63

5.9

2.8

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1393

5664

2.30

172.73

2.6

3.4

—

Type 2 diabetes

1828

5093

2.13

171.58

2.4

3.8

—

Other soft tissue disorders, not elsewhere classified

1734

4792

2.15

167.60

3.1

3.6

—

Asthma, excluding more controls

1162

2341

2.63

167.44

2.6

—

Autoimmune diseases

1967

4881

2.08

167.34

2.9

3.7

—

Disorders of lipoprotein metabolism and other lipidaemias

1611

4602

2.21

167.14

2.9

3.4

—

Hypertensive Renal Disease

217

270

9.18

166.29

1.9

4.0

—

Gout, idiopatic and unspecified

779

2719

3.01

165.51

2.3

3.4

—

Reimbursement for rheumatic diseases

1211

5185

2.38

165.39

1.9

3.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

635

1132

3.60

163.62

3.2

3.6

—

Covid-19 confirmed case

927

3550

2.70

163.45

4.1

3.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1754

5079

2.11

162.73

2.3

3.8

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

287

296

7.18

161.33

2.5

4.1

—

Disorders of parathyroid gland

635

1971

3.34

161.20

2.6

3.3

—

Complications of surgical and medical care, not elsewhere classified

1888

6533

2.01

157.98

3.0

3.4

—

Other specified/unspecified arthritis

629

1984

3.27

157.87

2.9

3.8

—

Autoimmune diseases related-to ILD

1590

6589

2.10

156.31

2.5

3.5

—

Pain in limb

1517

4735

2.18

155.79

3.0

3.6

—

Gout, unspecified

657

2158

3.21

155.71

2.3

3.2

—

Atrial fibrillation and flutter with reimbursement

512

819

4.09

155.45

3.3

3.6

—

Cardiac arrhythmias

899

2126

2.79

155.30

3.4

3.9

—

Other medical care

1057

3955

2.47

152.68

5.0

3.1

—

Cerebrovascular diseases (FINNGEN)

515

960

3.88

152.42

3.1

3.6

—

Insulin, intermediate and long-acting

1227

5333

2.29

152.24

2.4

3.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1454

6197

2.15

151.65

2.9

3.5

—

Diabetes, insulin treatment (Kela reimbursement)

1884

5780

2.00

150.90

2.3

3.8

—

Used for control exclusion in common control thyroid runs

1819

4528

2.06

150.58

2.9

3.6

—

Asthma (only as main-diagnosis), excluding more controls

1041

2341

2.58

149.22

2.6

—

Gout, strict definition

604

1945

3.28

148.38

2.2

3.4

—

Spondylopathies

1574

4506

2.12

147.20

3.6

3.2

—

Provisional assignment of new diseases of uncertain etiology

1097

4749

2.36

147.02

3.9

3.0

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

89.52

146.86

7.6

1.1

—

Codes for special purposes

1098

4761

2.35

146.61

4.0

3.0

—

Diseases of oesophagus, stomach and duodenum

1932

5976

1.96

146.46

3.0

3.5

—

Percutaneous Coronary Intervention

1555

4581

2.12

145.45

2.8

3.7

—

Anaemia in chronic diseases classified elsewhere

155

149

12.39

145.08

2.0

4.3

—

Other pulmonary diagnosis

1296

2822

2.33

144.81

3.8

2.6

—

Cardiovascular diseases

650

1047

3.37

144.52

3.4

3.2

—

Presence of other functional implants

1326

4223

2.23

143.86

3.1

3.3

—

Low back pain

1372

4591

2.18

143.66

3.6

3.1

—

Polyneuropathies and other disorders of the peripheral nervous system

642

2184

3.08

142.75

3.6

3.3

—

Non-Hodgkin lymphoma, all, including Hilmo

426

1122

4.02

142.63

3.1

1.5

—

Excluding asthma or asthma-COPD overlap

1289

2822

2.32

142.31

3.7

2.6

—

Any reimbursement code in KELA

656

991

3.35

140.79

3.8

1.7

—

Ulcer of lower limb, not elsewhere classified

478

1378

3.67

140.21

2.7

3.3

—

Disorders of lens

1376

4011

2.18

139.24

3.3

3.4

—

Asthma

1225

2795

2.33

138.45

2.7

2.6

—

Coronary revascularization (ANGIO or CABG)

1535

4581

2.09

138.36

2.8

3.7

—

ILD differential diagnosis

1275

2822

2.29

137.36

3.7

2.6

—

Other and unspecified polyneuropathies, also in other diseases

584

1926

3.18

137.36

3.2

3.3

—

COPD differential diagnosis

1275

2823

2.29

137.27

3.7

2.6

—

Hyperkalaemia

256

464

6.06

137.01

3.2

3.4

—

Parasetamol

1123

2382

2.42

136.43

3.4

3.0

—

Bleeding

1662

6040

1.99

136.30

2.9

3.5

—

Dialysis

174

211

9.17

135.46

3.1

3.6

—

Emergency coronary revascularization (for ACS)

1695

5253

2.00

135.02

2.7

3.6

—

Other disorders of kidney and ureter

426

1167

3.87

134.97

2.4

3.6

—

Chronic nephritic syndrome

190

259

8.24

134.43

2.4

4.3

—

Diabetes medication

1807

5580

1.95

134.03

2.3

3.8

—

Asthma (mode)

1198

2822

2.30

133.04

2.8

2.6

—

2041

5685

1.88

131.86

4.7

2.8

—

Polymyalgia rheumatica

464

1372

3.60

131.23

2.2

3.5

—

Enlarged lymph nodes

372

943

4.09

130.26

2.2

3.4

—

Genitourinary diseases

895

1714

2.65

130.23

3.1

3.6

—

Ischemic heart diseases

1550

4650

2.03

130.14

3.0

3.7

—

Other disorders of skin and subcutaneous tissue

1412

6267

2.04

129.20

3.1

3.4

—

Major coronary heart disease event

1615

4966

2.00

128.62

2.8

3.7

—

Other CVD (FINNGEN)

295

454

5.26

128.44

3.8

3.6

—

Certain disorders involving the immune mechanism

490

1512

3.38

128.26

3.7

3.3

—

Type 2 diabetes, definitions combined

1669

5042

1.97

127.96

2.5

3.9

—

Malignant neoplasm

1450

4203

2.07

127.47

6.1

1.5

—

Non-invasive ventilation

443

1123

3.61

127.10

3.7

4.1

—

Endocrine, nutritional and metabolic diseases

1120

2458

2.33

126.26

3.1

3.8

—

Type 2 diabetes, strict (exclude DM1)

1673

5092

1.96

125.59

2.5

3.9

—

Certain infectious and parasitic diseases

1207

2714

2.26

125.46

3.6

2.5

—

Hard cardiovascular diseases

1509

4517

2.02

124.72

3.1

3.7

—

Rheumatoid arthritis

696

2349

2.73

123.81

2.1

3.8

—

Insulin, fast-acting

790

3199

2.53

123.68

2.3

3.3

—

Pain in throat and chest

1379

4045

2.07

122.50

3.3

—

Asthma (only as main-diagnosis)

1091

2795

2.29

122.23

2.7

2.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1267

5598

2.07

121.75

4.2

2.9

—

Malignant neoplasm, wide definition for exclusion

1451

4239

2.03

121.65

5.8

1.5

—

Persons encountering health services in other circumstances, wide

2050

5861

1.82

120.59

3.2

3.3

—

Cardiomyopathy in other diseases

41.00

120.24

10.2

3.3

—

Codeine or tramadol medication

1959

5903

1.84

120.21

3.3

—

Hypothyroidism (congenital or acquired)

257

228

6.45

119.98

4.1

1.6

—

Isolated proteinuria

146

167

9.95

119.56

5.3

3.6

—

Other diseases of intestines

1720

5194

1.90

119.16

3.2

3.3

—

Coagulation defects, purpura and other haemorrhagic conditions

488

1576

3.22

118.36

3.5

3.3

—

Diseases of arteries, arterioles and capillaries

1447

5490

1.99

118.35

2.5

3.5

—

Cardiomyopathy

436

1315

3.44

118.28

3.9

3.2

—

Acquired haemolytic anaemia

148

176

9.85

118.26

3.4

3.9

—

Type 2 diabetes, definitions combined, including avohilmo

1640

5016

1.93

118.26

2.5

3.9

—

Myelodysplastic syndrome, including Hilmo

163

217

8.60

118.21

2.7

1.4

—

Pure hypercholesterolaemia

1373

4481

2.03

117.36

2.8

3.4

—

Intestinal infectious diseases

1644

6712

1.88

116.75

4.5

3.0

—

Antihypertensive medication - note that there are other indications

646

1170

2.96

116.52

3.0

4.1

—

Hyperparathyroidism

519

1738

3.08

115.93

2.6

3.3

—

Hypothyroidism and >3 levothyroxin purchases

252

228

6.32

115.87

4.1

1.6

—

Hypothyroidism, levothyroxine purchases

252

228

6.32

115.87

4.1

1.6

—

Hypo-osmolality and hyponatraemia

475

1525

3.23

115.32

3.0

3.2

—

Explicit bacterial Sepsis

306

738

4.36

115.28

5.8

3.2

—

Syncope and collapse

846

3080

2.40

114.88

2.8

3.3

—

Symptoms and signs concerning food and fluid intake

279

630

4.63

113.96

2.4

3.3

—

Symptoms and signs involving the urinary system

1486

5980

1.92

112.23

2.9

3.5

—

Bronchitis

1852

6528

1.81

111.50

5.0

2.8

—

ILD medications: azathioprine

291

690

4.35

111.37

1.9

2.0

—

Neoplasms

989

2288

2.31

111.26

4.3

1.3

—

Senile cataract

1260

3800

2.07

111.07

3.4

3.5

—

Other diseases of pleura

1078

4532

2.14

110.67

2.8

3.3

—

Haemolytic anaemias

164

240

7.64

108.89

3.3

3.8

—

Streptococcal septicaemia

268

614

4.62

108.23

5.6

3.4

—

Other disorders involving the immune mechanism, not elsewhere classified

144

183

8.81

108.10

3.8

3.9

—

Insulin, fast-acting or short human

791

3417

2.37

107.30

2.3

3.3

—

Viral pneumonia

333

900

3.86

106.94

6.6

2.6

—

Examination and observation for other reasons

1021

2695

2.22

106.86

3.5

3.1

—

Medical observation and evaluation for suspected diseases and conditions

1131

2717

2.16

106.42

3.6

3.1

—

Other necrotizing vasculopathies (FG)

219

435

5.43

105.59

1.6

4.2

—

Purpura and other haemorrhagic conditions

370

1084

3.57

105.54

3.5

3.4

—

Abnormal findings on examination of urine, without diagnosis

183

309

6.50

105.49

5.0

3.6

—

Isolated proteinuria with specified morphological lesion

17.32

104.93

3.0

4.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

435

1412

3.21

104.88

2.3

3.6

—

Paroxysmal tachycardia

348

789

3.77

104.86

2.6

3.6

—

Other necrotizing vasculopathies

264

617

4.61

104.66

1.8

3.7

—

Complications of medical and surgical care

1367

6686

1.91

104.56

3.2

3.4

—

Other (not insulin) diabetes medications

1682

5512

1.83

104.45

2.4

3.8

—

Dorsalgia

1606

4660

1.87

103.25

3.6

3.1

—

Other dialysis

151

217

7.88

102.25

2.5

4.3

—

Hypertensive Heart Disease

558

1597

2.82

102.08

2.6

4.1

—

Hypothyroidism, drug reimbursement

173

168

7.40

101.21

4.0

1.7

—

Depression medications

257

235

5.55

99.33

3.1

1.6

—

Diseases of the skin and subcutaneous tissue

1655

4575

1.83

99.15

3.0

3.3

—

Lower back pain or/and sciatica

1781

6696

1.76

98.32

3.5

3.3

—

Postmenopausal osteoporosis with pathological fracture

242

565

4.65

96.37

2.5

3.1

—

Pain, not elsewhere classified

490

1773

2.82

96.19

3.3

—

Complications of procedures, not elsewhere classified

1416

6433

1.85

96.19

2.9

3.4

—

All influenza

521

1952

2.74

95.89

7.3

2.5

—

Symptoms and signs involving the circulatory and respiratory systems

1498

4067

1.86

94.49

3.3

—

Other arrhythmias

982

3587

2.09

94.44

3.0

3.5

—

Care involving use of rehabilitation procedures

1072

5004

2.00

94.19

2.8

3.1

—

Volume depletion

283

753

3.95

93.34

2.2

3.3

—

Any death

1294

4967

1.90

92.95

4.3

3.3

—

Other autoimmune haemolytic anaemias

12.90

91.04

2.2

3.7

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

442

689

3.25

91.00

3.4

3.3

—

Diverticular disease of intestine

1362

4733

1.86

90.55

3.5

3.4

—

Seropositive rheumatoid arthritis

503

1904

2.70

90.04

1.9

3.9

—

Nausea and vomiting

568

2242

2.54

89.74

3.3

—

Azathioprine

291

810

3.70

89.15

1.9

4.1

—

Abnormal findings on diagnostic imaging of lung

1049

5196

1.98

88.89

2.8

3.5

—

Hyperlipidaemia, other/unspecified

818

3551

2.17

88.51

3.0

3.4

—

Spondylopathies in diseases classified elsewhere

13.69

88.49

17.9

3.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

125

171

8.11

88.04

3.3

4.0

—

Fall on same level

1788

5744

1.72

87.73

3.0

3.5

—

Disorders of thyroid, IBD co-morbidities

231

351

4.70

87.34

2.7

3.9

—

Bacterial pneumoniae

784

3218

2.19

86.63

5.0

2.6

—

STROKE

908

2977

2.10

86.44

3.3

4.0

—

Enterocolitis due to Clostridium difficile

316

954

3.48

86.24

5.2

3.1

—

Biguanides

1621

5728

1.74

86.22

2.3

3.8

—

Haemorrhage from respiratory passages

721

2950

2.25

85.46

3.0

3.2

—

Non-follicular lymphoma

305

909

3.56

85.38

2.8

3.6

—

Diseases of the digestive system

948

4789

2.01

85.00

2.7

3.3

—

Thrombocytopenia, unspecified

232

577

4.28

84.53

3.1

3.6

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1802

5835

1.70

84.50

3.3

—

Other bacterial intestinal infections

431

1576

2.83

83.68

5.0

2.9

—

Conduction disorders

597

2028

2.44

83.28

2.5

3.3

—

AV-block

426

1341

2.87

82.91

2.7

3.1

—

Other acute lower respiratory infections

966

4731

1.98

82.65

4.8

3.0

—

Any event in cancer register

1403

4642

1.80

82.31

5.2

2.2

—

Intestinal infectious diseases

1880

6537

1.66

82.25

4.3

3.0

—

Diabetic retinopathy, excluding more controls

568

1254

2.62

82.18

2.1

2.8

—

Pleural effusion

427

1576

2.82

81.88

2.7

3.3

—

Persons encountering health services in other circumstances

699

3197

2.21

81.48

3.4

3.3

—

Coronary atherosclerosis

1212

4176

1.87

80.50

2.8

3.7

—

Constipation

1555

6345

1.72

80.11

3.8

3.3

—

Disorders of choroid and retina

1501

6245

1.73

79.90

2.8

3.5

—

Exposure to unspecified factor

1606

6893

1.69

79.64

3.0

3.4

—

Dermatitis

1080

5826

1.87

79.44

3.0

3.5

—

Spinal stenosis

1017

4050

1.94

78.90

3.2

—

Unspecified haematuria

905

3806

2.01

78.88

2.7

3.4

—

Osteopathy in diseases classified elsewhere

19.25

77.90

18.2

6.1

—

Type 1 diabetes

433

1641

2.69

77.61

2.0

3.7

—

Type 1 diabetes, wide definition, subgroup 1

351

1198

2.99

76.78

2.1

3.8

—

Other abnormalities of plasma proteins

101

10.53

76.68

3.8

4.8

—

Bacterial intestinal infections, IBD co-morbidities

433

1661

2.69

76.59

5.1

3.2

—

Implicit fungal Sepsis

194

454

4.52

76.42

3.2

3.3

—

Presence of cardiac and vascular implants and grafts

935

3580

1.98

76.31

2.4

3.2

—

Donors of organs and tissues

15.18

76.28

16.6

4.7

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1040

2718

1.96

76.22

3.4

3.1

—

Major coronary heart disease event excluding revascularizations

1168

4279

1.85

76.22

2.7

3.7

—

Ischaemic heart disease, wide definition

1395

4986

1.76

76.09

2.9

3.7

—

Asthma-related infections

1009

5311

1.89

75.66

2.9

3.4

—

Asthma, hospital admission 2, infections

1009

5311

1.89

75.66

2.9

3.4

—

Other dorsopathies, not elsewhere classified

1521

4661

1.72

75.28

3.4

3.1

—

Other nutritional deficiencies

1023

5204

1.87

74.91

2.3

3.6

—

Continuous positive airway pressure

342

961

3.07

74.90

2.7

3.8

—

GI-bleeding

718

3459

2.12

74.80

2.6

3.3

—

Rheumatoid arthritis, including avohilmo

755

3707

2.08

74.59

2.1

3.5

—

Peripheral artery disease

983

4158

1.92

74.37

2.4

3.5

—

Other disorders of white blood cells

179

404

4.74

74.13

2.4

3.9

—

Non-Hodgkin lymphoma, all

162

338

5.19

74.06

3.2

1.4

—

Bacterial pneumonia, not elsewhere classified

729

3090

2.12

74.02

4.8

2.6

—

Other cataract

847

3227

2.02

73.96

3.1

3.4

—

Other diseases of pericardium

142

263

5.77

73.93

3.0

3.3

—

Diseases of the musculoskeletal system and connective tissue

660

1446

2.31

73.15

3.5

3.3

—

Coxarthrosis [arthrosis of hip](FG)

948

3486

1.94

72.99

2.8

3.9

—

Other diseases of the digestive system

714

3465

2.11

72.98

2.7

3.3

—

Other bacterial intestinal infections

480

1977

2.49

72.93

4.8

2.9

—

Neurological diseases, wide definition

290

393

3.74

72.86

2.9

3.7

—

Diseases of the respiratory system

960

2450

1.98

72.85

3.9

2.6

—

Infections of the skin and subcutaneous tissue

948

5021

1.90

72.38

3.2

—

Headache

847

3440

1.99

72.02

2.8

3.2

—

Other and unspecified dermatitis

904

4783

1.92

71.64

3.1

3.5

—

Other abnormal findings of blood chemistry

146

287

5.45

71.23

4.5

4.3

—

Other retinal disorders

1238

5560

1.76

71.09

2.5

3.4

—

Agranulocytosis

272

843

3.36

71.07

4.6

3.7

—

Other disorders of urethra and urinary system

1172

4781

1.79

70.69

3.2

3.5

—

Diseases of liver

681

3285

2.12

70.64

2.2

3.5

—

Fracture of lumbar spine and pelvis

512

2210

2.38

69.99

3.1

3.2

—

Asthma-related pneumonia

731

3627

2.05

69.74

3.0

3.3

—

Primary hyperparathyroidism

294

968

3.18

69.66

3.0

3.4

—

Obesity due to excess calories

740

3692

2.03

69.61

2.3

3.6

—

Asthma, hospital admissions 3, pneumonia

731

3640

2.04

69.05

3.0

3.3

—

Asthma-related pneumonia or sepsis

731

3640

2.04

69.05

3.0

3.3

—

Gastrointestinal diseases

728

1707

2.16

68.76

3.7

3.0

—

Osteomyelitis

189

471

4.25

68.62

2.7

3.7

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1085

6074

1.79

68.48

3.0

3.4

—

Disorders of gallbladder, biliary tract and pancreas

1640

6410

1.63

68.44

3.4

3.3

—

Spondylosis

963

4258

1.87

68.21

2.8

3.3

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

14.55

67.93

9.7

4.7

—

Bacterial pneumonia (organism specified)

877

4229

1.91

67.52

5.2

3.0

—

Asthma (diagnoses ohter than nonallergic)

1383

6936

1.67

66.95

2.5

3.5

—

Disorders of continuity of bone

201

530

3.93

66.95

3.8

3.5

—

Type 1 diabetes, wide definition

358

1346

2.71

65.32

2.1

3.7

—

Hypokalaemia

270

878

3.18

64.98

2.5

3.4

—

Myocardial infarction

938

3577

1.88

64.89

2.7

3.7

—

Benign neoplasm of colon, rectum, anus and anal canal

1218

6261

1.71

64.85

2.8

3.5

—

Venous thromboembolism

1040

5720

1.78

64.74

4.4

3.1

—

Other specific joint derangements/joint disorders

968

3400

1.86

64.63

3.0

3.7

—

Acute bronchitis

753

3802

1.97

64.62

5.0

3.0

—

ILD, hospital admission 2, with pulmonary infections

249

776

3.35

64.55

2.7

2.4

—

Soft tissue disorders

1529

4810

1.65

64.47

2.7

3.6

—

Diabetic maculopathy, excluding more controls

246

761

3.35

64.35

1.8

4.0

—

Adjustment and management of implanted device

429

1782

2.48

64.32

2.9

—

Other diseases of urinary system

1590

5549

1.63

64.29

3.0

3.5

—

Use of hypnotics and sedatives

1685

6101

1.60

64.21

4.0

3.1

—

Arthropathies

1215

3531

1.76

64.14

2.9

3.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

917

3962

1.87

63.93

2.3

3.5

—

Weight loss

256

819

3.27

63.63

2.4

3.5

—

Malignant neoplasm of bone and articular cartilage

14.89

63.11

10.8

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

741

3789

1.97

63.09

3.3

3.2

—

COPD (mode)

564

2044

2.21

62.58

2.1

2.7

—

Hernia of abdominal wall, postoperative

294

1021

2.94

62.57

2.9

2.7

—

Osteonecrosis

174

440

4.18

61.99

9.8

3.5

—

Gonarthrosis [arthrosis of knee](FG)

1145

3833

1.76

61.92

3.1

3.8

—

Cytomegalovirus infection, IBD co-morbidity

142

7.42

61.89

6.9

3.8

—

Dorsopathies

1495

4662

1.64

61.85

3.2

3.1

—

Obesity

936

5046

1.81

61.81

2.2

3.6

—

Abnormal weight loss

245

778

3.30

61.77

2.4

3.5

—

Obesity and other hyperalimentation

940

5070

1.81

61.67

2.2

3.6

—

IgA nephropathy (IgA glomerulonephritis)

152

7.12

61.61

1.6

3.6

—

Other functional intestinal disorders

789

3878

1.92

61.60

3.5

3.4

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

22.27

61.27

11.5

1.3

—

Endocarditis

117

217

5.78

60.95

2.7

3.2

—

Nerve, nerve root and plexus disorders

1693

6655

1.57

60.76

3.3

—

Pacemaker

750

3801

1.94

59.81

2.5

3.3

—

Marginal zone B-cell lymphoma, including Hilmo

109

8.61

59.66

2.0

1.4

—

Chronic lower respiratory diseases

1800

6224

1.55

59.46

2.6

3.6

—

DVT of lower extremities and pulmonary embolism

832

4542

1.86

59.30

4.8

3.2

—

Other/unspecified cytomegaloviral diseases

118

8.06

59.30

7.4

3.9

—

Chronic tubulo-interstitial nephritis

112

205

5.81

59.01

1.9

3.9

—

Cytomegaloviral disease

150

6.98

58.72

6.9

3.6

—

Amputation

286

1021

2.93

58.68

2.6

3.5

—

Coxarthrosis

864

3099

1.87

58.50

2.7

3.8

—

Fungal Sepsis

129

271

5.09

58.38

3.6

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

11.34

58.29

9.8

1.2

—

Viral infections characterized by skin and mucous membrane lesions

703

3669

1.94

58.09

5.2

3.0

—

Dermatitis and eczema

1691

6797

1.55

58.08

3.0

3.4

—

Calcific aortic valvular stenosis, including rheumatic fever

693

3495

1.97

58.07

2.9

3.2

—

Benign neoplasms

1443

4944

1.62

57.84

3.2

—

Calcific aortic valvular stenosis, diagnosis (helper)

690

3485

1.97

57.75

2.9

3.2

—

Operations 2 for CAVS

690

3485

1.97

57.75

2.9

3.2

—

Calcific aortic valvular stenosis

690

3487

1.97

57.65

2.9

3.2

—

Calcific aortic valvular stenosis, operated

690

3487

1.97

57.65

2.9

3.2

—

Other joint disorders

1146

3530

1.73

57.46

2.7

3.6

—

Symptoms and signs involving the digestive system and abdomen

1552

4903

1.60

57.45

3.3

—

684

3522

1.95

57.37

3.3

—

Polyarthrosis

401

1571

2.43

57.04

2.6

4.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1555

6375

1.58

57.00

3.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

1537

6487

1.57

56.53

4.0

3.0

—

Hypoparathyroidism

126

268

5.08

56.39

2.7

4.0

—

Sleep apnoea

1504

6210

1.58

56.19

2.8

3.6

—

Chronic apical periodontitis

1711

6359

1.54

56.18

3.9

3.1

—

Vocal cord dysfunction

182

444

3.74

55.93

3.4

4.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1506

6572

1.58

55.84

2.9

3.4

—

General examination and investigation of persons without complaint and reported diagnosis

936

2714

1.82

55.55

3.6

3.1

—

Sulfasalazine

445

1998

2.26

55.29

2.0

3.7

—

Amputation of toe

217

688

3.33

55.16

2.5

3.6

—

Arthrosis

1066

3404

1.74

54.87

2.6

3.7

—

Viral infections characterized by skin and mucous membrane lesions

1299

6965

1.61

54.64

4.3

3.2

—

Implicit fungal Sepsis

120

252

5.10

54.38

3.8

3.6

—

Intracranial trauma

781

2975

1.86

53.78

3.4

3.6

—

Pain (limb, back, neck, head abdominally)

1094

3217

1.72

53.36

3.4

3.2

—

Hydronephrosis

224

734

3.15

53.21

2.4

3.7

—

Immunodeficiency with predominantly antibody defects

145

6.64

53.14

6.2

3.8

—

Organ-limited amyloidosis

21.56

53.11

6.3

2.8

—

Factors influencing health status and contact with health services

434

912

2.41

53.08

3.6

2.6

—

Other/unspecified dorsalgia

600

3046

1.98

52.50

4.0

3.2

—

Other respiratory diseases principally affecting the interstitium

424

1919

2.28

52.34

2.8

3.3

—

Drug-induced osteoporosis with pathological fracture

133

7.22

52.28

2.0

4.5

—

Peripheral artery operations in Hilmo

322

1292

2.58

52.22

2.5

3.4

—

Pulmonary heart disease, diseases of pulmonary circulation

653

3461

1.92

51.98

4.0

3.2

—

Myelodysplastic syndrome

10.83

51.98

2.0

1.2

—

Seronegative rheumatoid arthritis

241

835

2.98

51.94

2.3

4.0

—

Undetermined asthma, excluding more controls

205

645

3.25

51.87

2.3

—

ILD, hospital admissions 3, with pneumonia sepsis

222

740

3.13

51.59

2.7

2.8

—

Other and unspecified disorders of white blood cells

127

292

4.65

51.52

2.4

4.2

—

Acute myeloid leukaemia and myelodysplastic syndromes

131

6.97

51.33

1.8

1.3

—

Failure and rejection of transplanted organs and tissues

9.98

51.26

8.5

4.1

—

Idiopathic gout

251

905

2.90

50.73

2.0

3.5

—

Immunodeficiencies

127

295

4.54

50.65

5.8

3.8

—

Fibrosis and cirrhosis of liver

203

652

3.26

50.37

1.7

3.8

—

Other diseases of blood and blood-forming organs

180

540

3.50

49.89

3.6

3.8

—

Angina pectoris

994

3941

1.70

49.68

3.1

3.7

—

Diseases of the eye and adnexa

990

2891

1.73

49.41

3.4

3.1

—

Abdominal and pelvic pain

1504

4903

1.55

49.32

3.4

3.3

—

Viral pneumonia (known virus, not influenza)

185

5.70

49.30

9.4

3.7

—

Other (seronegative) rheumatoid arthritis, wide

391

1753

2.29

49.25

2.1

3.4

—

Other and unspecified diseases of blood and blood-forming organs

182

5.74

49.11

4.3

3.9

—

Other antidepressants

1608

5443

1.53

48.86

2.9

3.5

—

Lymphoid leukaemia

171

505

3.59

48.83

3.7

—

Osteonecrosis due to drugs

114

7.57

48.58

15.2

4.9

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

331

1392

2.45

48.55

1.5

3.6

—

Sleep apnoea, including avohilmo

1527

6249

1.53

48.33

2.8

3.6

—

Acute upper respiratory infections of multiple and unspecified sites

1087

4958

1.64

48.32

5.9

2.8

—

Falls/tendency to fall

1520

4981

1.54

47.95

3.0

3.5

—

Other gastritis (incl. Duodenitis)

446

2131

2.14

47.76

2.9

3.5

—

Injuries to the head

1635

6750

1.50

47.74

3.2

3.4

—

Hypocalcemia

170

5.89

47.47

4.5

4.0

—

Myocardial infarction, strict

834

3426

1.76

47.26

2.4

3.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

969

5907

1.66

46.99

2.8

3.4

—

Later onset COPD, excluding more controls

421

1501

2.22

46.89

2.2

2.7

—

Chronic lymphocytic leukaemia

102

217

5.10

45.77

1.9

1.4

—

Chronic lymphocytic leukaemia, helper endpoint

102

217

5.10

45.77

1.9

1.4

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

102

217

5.10

45.77

1.9

1.4

—

Zoster [herpes zoster]

384

1769

2.23

45.32

5.9

3.3

—

Cardiomyopathies, Primary/intrinsic

240

893

2.76

45.29

2.7

3.1

—

Abnormalities of heart beat

552

2838

1.93

45.02

2.9

3.3

—

Gastro-oesophageal reflux disease

1048

5652

1.62

45.01

3.1

3.6

—

Seropositive rheumatoid arthritis, wide

503

2566

2.00

44.99

1.9

3.5

—

Myocardial infarction, without ST-elevation

832

4491

1.72

44.99

2.7

3.3

—

Pulmonary embolism

583

3135

1.90

44.48

4.2

3.1

—

Arthropathies in other diseases classified elsewhere

104

229

4.81

44.46

2.0

4.2

—

Benign neoplasm: Colon

1010

6025

1.62

44.45

2.9

3.5

—

Rare circulating lymphoid malignancy, including Hilmo

183

5.38

44.43

6.7

1.4

—

Other pleural conditions

256

997

2.66

44.41

3.2

3.4

—

Disorders of eyelid, lacrimal system and orbit

1343

6733

1.53

44.39

3.4

3.3

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

490

2490

2.01

44.34

1.9

3.5

—

Gonarthrosis

968

3326

1.67

44.28

2.8

3.8

—

Benzodiazepine use

1504

6981

1.49

44.09

3.4

3.3

—

Pulmonary heart disease

583

3148

1.89

43.92

4.2

3.1

—

Pain in joint

817

3026

1.74

43.91

3.1

3.2

—

Fentanyl

223

811

2.83

43.87

8.0

2.7

—

Pneumonia due to other infectious organisms, not elsewhere classified

208

5.01

43.84

7.1

3.0

—

Other/unspecified seropositive rheumatoid arthritis

495

2538

1.99

43.65

1.9

3.5

—

Noninfective enteritis and colitis

705

4036

1.77

43.19

3.0

3.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

183

605

3.14

43.10

2.2

1.5

—

Acute sinusitis

689

3619

1.78

43.09

5.0

2.8

—

Sequelae of external causes of morbidity and mortality

480

2447

2.00

43.04

3.2

3.4

—

Sub-endpoint used in defining T1D endpoints

472

2346

2.01

43.04

2.0

3.2

—

Diseases of spleen

125

6.53

42.91

2.3

4.2

—

Other interstitial pulmonary diseases

352

1605

2.26

42.83

2.5

3.4

—

ILD, hospital admissions

347

1575

2.27

42.71

2.5

3.4

—

Giant cell arteritis

136

379

3.84

42.61

1.6

4.0

—

Acute upper respiratory infections

1564

6566

1.48

42.60

5.0

2.9

—

Interstitial lung disease endpoints

352

1614

2.25

42.25

2.5

3.3

—

Interstitial lung disease

352

1614

2.25

42.25

2.5

3.3

—

Methotrexate

241

930

2.65

42.20

2.3

4.0

—

Periodontitis

1480

6709

1.49

42.13

3.5

3.3

—

All influenza (not pneumonia)

244

948

2.63

42.09

6.2

2.6

—

Adrenocortical insufficiency

100

224

4.73

41.88

3.2

4.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

929

5779

1.63

41.70

2.9

3.4

—

Cardiomyopathy (excluding other)

243

950

2.63

41.58

2.6

3.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

287

1214

2.43

41.49

2.7

3.4

—

Other and unspecified acquired haemolytic anaemias

9.46

41.34

3.2

2.1

—

Sicca syndrome [Sjögren]

181

610

3.07

41.23

2.2

3.8

—

Chronic periodontitis, including avohilmo

1472

6711

1.48

41.20

3.5

3.3

—

Obesity related asthma

555

3012

1.87

41.03

2.1

3.6

—

Peripheral arterial reconstruction

400

1951

2.11

40.92

2.3

3.2

—

Other and unspecified aplastic anaemias

9.53

40.83

2.5

5.1

—

Cirrhosis of liver, NAS

151

462

3.45

40.82

1.7

4.1

—

Meniscus derangement

812

3250

1.70

40.80

3.3

3.8

—

Persons encountering health services for examination and investigation

902

2718

1.68

40.56

3.4

3.1

—

Undetermined asthma

205

743

2.82

40.50

2.3

—

Concussion

644

2959

1.79

40.47

3.1

3.6

—

Other intervertebral disc disorders

1174

4585

1.55

40.29

3.1

3.2

—

Cardiomyopathy, other and unspecified

158

498

3.28

40.29

3.1

3.2

—

Other CVD

435

2200

2.03

40.13

3.4

3.1

—

Cutaneous abscess, furuncle and carbuncle

401

1964

2.07

40.10

2.7

3.3

—

Charcot foot

113

6.58

40.00

2.0

4.1

—

Type of accident

474

2465

1.95

39.99

2.9

3.2

—

Injuries to the thorax

781

4705

1.68

39.96

3.3

—

Dental operations

1033

3325

1.61

39.82

3.5

2.8

—

Fracture of rib(s), sternum and thoracic spine

565

3116

1.85

39.82

3.5

3.2

—

Other noninfective gastroenteritis and colitis

409

2024

2.05

39.72

3.3

3.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

501

2660

1.91

39.68

2.9

3.2

—

Neurological diseases

1125

3611

1.58

39.61

3.0

3.6

—

Chronic ulcer of skin, not elsewhere classified

175

594

3.07

39.54

2.5

3.5

—

Hernia

1398

6363

1.48

39.47

3.2

3.3

—

Secondary uncertain malignant neoplasm

261

1085

2.47

39.27

2.2

1.5

—

Viral pneumonia (unknown virus, not influenza)

150

466

3.34

39.24

6.0

3.7

—

Missing teeth due to accident, extraction or parodontitis

1009

6112

1.57

39.19

3.5

3.4

—

Cough

596

3161

1.80

39.14

3.3

3.4

—

Other disorders of adrenal gland

108

270

4.19

39.12

3.1

4.1

—

Retention of urine

659

3111

1.77

38.97

2.7

3.4

—

Eosinophilic disease (BM)

8.15

38.81

2.4

2.2

—

Injuries to the hip and thigh

844

4717

1.64

38.78

2.8

3.3

—

Zoster [herpes zoster]

837

5099

1.64

38.49

4.5

3.2

—

Gastroduodenal ulcer

513

2768

1.88

38.46

2.7

3.3

—

Cystic kidney disease

201

4.75

37.90

1.5

3.9

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

126

361

3.71

37.84

3.3

4.0

—

Other metabolic disorders

202

755

2.73

37.72

4.0

3.3

—

Decubitus ulcer and pressure area

167

568

3.08

37.70

2.1

3.3

—

Viral hepatitis, IBD co-morbidity

118

5.88

37.59

2.5

3.7

—

Hypotension

384

1906

2.07

37.44

3.5

3.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

135

405

3.44

37.28

3.4

3.2

—

Symptoms and signs involving the skin and subcutaneous tissue

1048

6727

1.54

37.23

3.8

3.3

—

Folate deficiency anaemia

8.82

37.13

1.6

5.0

—

Cerebrovascular diseases

1259

5975

1.50

37.08

3.0

3.5

—

Asthma, hospital admissions , main diagnosis only

1166

6884

1.51

37.01

2.6

3.4

—

Pneumocystosis

148

5.59

36.96

9.0

3.8

—

Other arthrosis

764

3184

1.68

36.91

2.7

3.9

—

Other disorders of ear

1403

6324

1.46

36.87

3.5

3.3

—

Statin medication

848

2914

1.65

36.79

2.9

4.1

—

Hepatomegaly and splenomegaly, not elsewhere classified

9.04

36.69

2.5

4.4

—

Other disorders of bone

275

1202

2.33

36.69

7.0

3.0

—

Fracture of femur

545

2754

1.83

36.63

3.0

3.2

—

Injuries to the shoulder and upper arm

1272

6983

1.48

36.49

3.4

3.3

—

ILD, hospital admissions 1, main diag only

309

1432

2.22

36.25

2.7

3.4

—

Diabetic retinopathy

706

2602

1.73

36.22

2.2

2.7

—

Polycystic kidney disease

165

5.12

36.14

1.4

4.1

—

Vascular disorders of the intestines

173

615

2.93

35.95

2.2

3.1

—

Hypothyroidism, strict autoimmune

981

4143

1.57

35.91

3.3

3.7

—

Sequelae with surgical and medical care as external cause

384

1936

2.03

35.74

2.9

3.5

—

Haemorrhage, not elsewhere classified

100

253

4.15

35.72

2.5

3.5

—

Dizziness and giddiness

1153

6132

1.50

35.69

2.9

3.5

—

Cystic kidney disease

211

4.50

35.61

1.5

4.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

443

2347

1.92

35.42

2.0

4.0

—

Glucagon-like peptide-1 (GLP-1) analogues

443

2347

1.92

35.42

2.0

4.0

—

Marginal zone B-cell lymphoma

9.97

35.37

1.5

1.3

—

Sciatica+with lumbago

716

4001

1.66

35.04

3.2

3.3

—

Sleep disorders (combined)

1632

6072

1.42

35.01

2.7

3.5

—

Other and unspecified immunodeficiencies with predominantly antibody defects

8.97

34.81

7.4

5.0

—

Discitis, unspecified

119

5.99

34.69

2.8

3.7

—

Congenital malformations of the urinary system

116

332

3.62

34.56

1.7

3.8

—

Diffuse large B-cell lymphoma, helper endpoint

115

329

3.67

34.50

2.1

1.4

—

Diffuse large B-cell lymphoma, including Hilmo

115

329

3.67

34.50

2.1

1.4

—

Diffuse large B-cell lymphoma

115

329

3.67

34.50

2.1

1.4

—

Episodal and paroxysmal disorders

1517

5410

1.44

34.44

2.6

3.6

—

Other/unspecified rheumatoid arthritis

261

1159

2.32

33.94

1.9

3.3

—

Diagnoses used for exclusion with ILD

473

2599

1.85

33.85

2.5

3.1

—

199

780

2.60

33.82

2.9

3.6

—

Other external causes of accidental injury

1115

3698

1.52

33.59

3.2

3.5

—

Cellulitis

363

1832

2.02

33.58

3.2

3.3

—

Cholelithiasis, broad definition with cholecystitis

1311

6112

1.45

33.58

3.5

3.4

—

Small fibre neuropathy

231

4.27

33.49

3.6

3.9

—

Abnormal findings on diagnostic imaging of other body structures

258

1146

2.31

33.44

3.4

3.7

—

SLE (Finngen)

172

4.74

33.24

1.8

4.0

—

Myalgia

333

1634

2.07

33.20

3.0

3.6

—

Gout due to impairment of renal function

7.07

33.10

1.6

5.0

—

Temporal arteritis

112

327

3.64

32.79

1.6

4.0

—

Asthma, including avohilmo

1663

6735

1.39

32.79

2.6

3.5

—

Accidents

1110

3698

1.51

32.76

3.2

3.5

—

Exclusions for E4_PCOS_BROAD

259

1161

2.27

32.61

3.5

3.4

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

768

3241

1.63

32.61

3.9

1.5

—

Other diseases of liver

303

1449

2.13

32.56

2.8

3.5

—

Spondyloarthritis

284

1326

2.18

32.36

2.5

3.4

—

Caries of dentine, including avohilmo

1246

4355

1.47

32.29

3.2

—

Asthma/COPD (KELA code 203)

1301

6221

1.44

32.19

2.6

3.6

—

Valvular operations

249

1108

2.30

32.07

2.3

3.1

—

Other diseases of intestine

270

1244

2.22

32.00

2.6

3.4

—

Abnormal results of function studies

164

602

2.80

31.97

3.3

4.0

—

Congenital malformations of the urinary system

119

367

3.35

31.56

1.7

3.8

—

Sarcoidosis

238

1048

2.33

31.50

2.5

3.4

—

Fracture of shoulder and upper arm

580

3444

1.70

31.43

3.8

3.2

—

Diseases of oral cavity, salivary glands and jaws

954

3198

1.55

31.25

3.5

2.8

—

Shoulder lesions

1116

4594

1.48

31.03

2.9

3.6

—

Idiopathic thrombocytopenic purpura

196

4.37

30.84

3.9

3.5

—

Myeloid leukaemia

211

4.25

30.57

2.7

4.2

—

Unspecified acute lower respiratory infection

248

1124

2.25

30.55

4.6

2.9

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

431

2379

1.85

30.54

2.2

3.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

726

3109

1.62

30.46

3.7

1.5

—

Microscopic polyangiitis

10.66

30.39

1.3

5.6

—

Pericarditis

202

4.24

30.36

2.9

3.2

—

Conductive and sensorineural hearing loss

1262

5975

1.44

30.31

3.5

3.3

—

Any operation in hilmo

19.63

30.31

2.3

1.1

—

Mycoses

430

2375

1.84

30.27

3.7

3.3

—

Pneumonia derived septicemia

234

4.00

30.23

6.7

3.5

—

Disorders of lacrimal system

656

4058

1.63

30.12

3.7

3.4

—

Giant cell arteritis with polymyalgia rheumatica

112

346

3.44

30.06

1.6

3.8

—

Protozoal diseases

227

4.08

30.02

8.2

4.1

—

Unspecified nephritic syndrome

155

4.83

29.95

2.8

4.5

—

Other disorders of lacrimal gland

543

3216

1.71

29.91

3.9

3.4

—

Convulsions, not elsewhere classified

285

1355

2.10

29.81

2.2

3.1

—

Elevated blood glucose level

154

569

2.78

29.69

3.1

3.6

—

Leisure time condition

294

1441

2.08

29.61

2.6

3.3

—

Nonischemic cardiomyopathy

193

797

2.49

29.58

3.5

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

179

713

2.56

29.51

4.3

3.2

—

Solid cancers, helper endpoint

1048

4190

1.49

29.46

3.0

1.5

—

Other viral diseases

346

1789

1.95

29.45

5.7

3.2

—

Persons with potential health hazards related to communicable diseases

381

2022

1.88

29.33

3.4

3.1

—

Chronic gastritis

494

2870

1.75

29.30

2.3

3.5

—

External causes of morbidity and mortality

855

2759

1.56

29.28

3.3

3.4

—

Malnutrition

134

5.11

29.27

1.9

4.1

—

Other reaction to severe stress, and adjustment disorders

404

2208

1.85

29.22

4.1

3.2

—

Deforming dorsopathies

404

2213

1.85

29.14

3.5

3.3

—

Gingivitis and periodontal diseases

1500

5588

1.39

29.00

3.4

3.2

—

Pneumococcal septicemia

223

4.01

28.98

6.5

3.4

—

Non-allergic asthma (mode), excluding more controls

235

1053

2.24

28.88

2.9

2.4

—

Cholelithiasis

1240

6040

1.43

28.74

3.5

3.4

—

Cystitis

1188

4930

1.44

28.64

3.0

3.4

—

Pyogenic arthritis

134

469

2.95

28.64

3.3

4.1

—

L01XX Other antineoplastic agents

148

549

2.82

28.63

8.4

3.5

—

Myocarditis

163

4.47

28.60

3.7

2.8

—

Diseases of pulp and periapical tissues and dental caries

1055

3671

1.48

28.46

3.3

3.0

—

Fibromyalgia

133

464

2.93

28.44

3.0

3.4

—

Diseases of pulp and periapical tissues, including avohilmo

1491

5596

1.39

28.23

3.5

3.1

—

Eosinophilia

101

5.78

28.11

2.4

4.8

—

Other specified/unspecified systemic involvement of connective tissue

113

363

3.22

28.10

1.9

4.3

—

Amputation of foot

225

4.00

28.06

2.4

3.9

—

Sensorineural hearing loss

1214

5834

1.42

27.87

3.4

3.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

610

3790

1.63

27.81

3.0

3.4

—

Malignant neoplasm of skin

752

3319

1.57

27.73

3.7

1.5

—

Drug-induced adrenocortical insufficiency

121

5.25

27.72

4.4

4.0

—

Gastric ulcer

335

1769

1.93

27.34

3.0

3.4

—

Any mental disorder

1565

5748

1.37

27.32

3.0

3.5

—

Rheumatism, unspecified

227

1042

2.22

27.20

2.1

3.9

—

Dental caries, including avohilmo

1162

4151

1.44

27.18

3.2

—

Candidiasis

222

1012

2.24

27.06

4.1

3.4

—

COPD

796

4300

1.53

27.04

2.0

3.6

—

Hypertrophic cardiomyopathy

110

358

3.23

27.00

4.5

3.9

—

Vitamin deficiency, wide

101

311

3.37

26.98

3.2

4.0

—

Vitamin deficiency

101

311

3.37

26.98

3.2

4.0

—

Biological medication for rheuma

218

987

2.24

26.90

2.0

3.6

—

Other viral diseases

414

2329

1.78

26.53

5.2

3.1

—

Diabetic retinopathy, strict definition

352

1684

1.89

26.20

1.9

2.7

—

Other specified/unspecified necrotizing vasculopathies

6.30

26.19

2.3

4.7

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

256

1251

2.09

26.13

2.2

1.5

—

Other diseases of anus and rectum

481

2857

1.70

26.07

3.4

3.3

—

Other infectious diseases

182

777

2.41

26.06

3.9

3.4

—

Diaphragmatic hernia

612

3872

1.60

26.06

3.1

3.4

—

Systemic lupus erythematosus

209

3.89

25.79

1.8

4.4

—

Myeloproliferative diseases

177

752

2.43

25.71

3.4

3.6

—

Diseases of the myoneural junction and muscle

227

1072

2.17

25.45

2.5

3.3

—

Other respiratory disorders and diseases

386

2180

1.80

25.44

2.7

3.2

—

Other diseases of the respiratory system

386

2180

1.80

25.44

2.7

3.2

—

Early onset COPD, excluding more controls

281

1431

1.99

25.37

1.9

2.5

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

186

813

2.35

25.24

3.9

3.5

—

Nonhereditary hypogammaglobulinemia

7.07

25.23

4.0

4.2

—

Stroke, including SAH

1063

5444

1.43

25.20

3.0

3.5

—

Heart failure and hypertrophic cardiomyopathy

153

4.53

25.05

4.0

4.1

—

Allergic asthma (mode), excluding more controls

205

910

2.22

24.97

2.4

2.3

—

Pruritus

179

772

2.37

24.95

2.7

3.7

—

Acute and subacute iridocyclitis

296

1547

1.94

24.91

3.6

3.3

—

Noninfectious colitis NAS

214

995

2.19

24.85

3.3

3.5

—

Diabetic neuropathy

265

1335

2.04

24.82

2.0

2.5

—

Dermatitis due to substances taken internally

100

322

3.20

24.78

5.0

4.2

—

Dysphagia

411

2380

1.75

24.74

3.3

—

Candidiasis

402

2316

1.76

24.58

3.4

3.3

—

Sulfonylureas

649

3334

1.57

24.57

2.0

3.6

—

Other infectious diseases

159

657

2.49

24.55

3.7

3.5

—

DVT of lower extremities

329

1790

1.87

24.52

5.5

3.4

—

Acute pancreatitis

330

1798

1.87

24.46

2.7

3.3

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

191

857

2.29

24.37

2.2

1.5

—

Stroke, excluding SAH

1026

5290

1.43

24.34

3.0

3.5

—

Other coagulation defects

130

490

2.72

24.20

3.5

3.4

—

Misadventures to patients during surgical and medical care

239

1176

2.07

23.99

3.1

3.5

—

Basal cell carcinoma, including avohilmo

691

3118

1.54

23.77

3.8

1.5

—

Membranous nephropathy

10.92

23.76

1.8

2.8

—

Ascites

152

625

2.50

23.73

1.6

3.4

—

Insulin, fast-acting (human)

188

845

2.26

23.69

2.1

3.3

—

Iridocyclitis

344

1917

1.82

23.66

3.4

3.2

—

Open wound of head

809

5337

1.47

23.59

2.8

3.3

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

6.78

23.40

5.2

4.7

—

Basal cell carcinoma

670

3030

1.55

23.32

3.8

1.5

—

Other and unspecified myopathies

175

775

2.32

23.12

2.5

3.4

—

Paralytic ileus and intestinal obstruction

424

2523

1.70

23.08

3.3

—

Suppurative and necrotic conditions of lower respiratory tract

125

475

2.73

23.08

3.5

3.9

—

Budesonide

181

810

2.27

23.07

3.0

4.1

—

Obesity, other/unspecified

402

2359

1.72

22.96

1.8

3.5

—

Phlebitis and thrombophlebitis (not including DVT)

356

2023

1.79

22.95

4.6

3.4

—

Chronic pancreatitis

219

1063

2.11

22.89

2.7

3.5

—

SLE, strict definition

208

3.71

22.87

1.9

4.1

—

SLE, ICD10

208

3.71

22.87

1.9

4.1

—

Problems related to lifestyle

142

576

2.51

22.65

2.0

3.8

—

Pneumonia due to Streptococcus pneumoniae

243

3.45

22.59

6.8

2.5

—

Other diseases of hard tissues of teeth

886

3155

1.46

22.55

3.2

2.8

—

Other chronic obstructive pulmonary disease

747

4174

1.49

22.54

2.0

3.6

—

Other or unspecified ileus, impaction or obstruction

315

1739

1.84

22.39

3.4

3.3

—

Cardiodefibrillation

646

4276

1.53

22.37

3.2

3.4

—

Invasive ventilation

144

596

2.49

22.21

2.7

3.7

—

Anterior Iridocyclitis

306

1679

1.85

22.20

3.5

3.3

—

Depression or dysthymia

974

3788

1.43

22.16

3.0

3.6

—

Other and unspecified vasculitis limited to skin

172

3.99

22.05

3.3

4.3

—

Chronic periodontitis, complicated

822

5677

1.45

21.99

3.1

3.5

—

Mixed connective tissue disease

115

429

2.76

21.93

1.9

3.9

—

Lumbar disc prolapse

819

4343

1.46

21.91

3.1

3.2

—

Vasculitis limited to skin, not elsewhere classified

192

3.79

21.76

3.2

4.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

149

631

2.42

21.75

5.0

3.5

—

Other diseases of arteries and capillaries

168

751

2.29

21.69

2.5

3.6

—

Spondylopathies (FG)

170

761

2.27

21.68

2.1

3.9

—

Collagenous colitis

161

707

2.33

21.67

3.6

3.7

—

Abnormality of white blood cells, not elsewhere classified

7.64

21.63

1.7

4.7

—

Psychiatric diseases

1387

5194

1.34

21.55

3.0

3.6

—

Acute pancreatitis (for exclusion)

330

1871

1.79

21.52

2.7

3.4

—

Respiratory insufficiency

139

572

2.48

21.46

2.5

2.4

—

Myeloproliferative diseases (CML excluded)

158

694

2.35

21.37

3.6

—

Extreme obesity with alveolar hypoventilation

299

3.13

21.34

2.0

4.0

—

Infective dermatitis

189

891

2.17

21.33

1.8

3.8

—

Other skin changes

318

1790

1.81

21.30

5.2

3.3

—

Oesophageal varices

332

3.01

21.24

1.5

4.0

—

Crystal arthropathies, rheuma endpoint

138

4.32

20.99

3.2

5.4

—

Other neurological diseases

1111

6422

1.37

20.94

3.1

3.4

—

Psoriatic and enteropathic arthropathies

157

691

2.31

20.91

1.9

4.0

—

Ischaemic Stroke, excluding all haemorrhages

960

5132

1.40

20.85

2.9

3.4

—

Follow-up examination after treatment for conditions other than malignant neoplasms

538

2267

1.58

20.78

3.6

3.1

—

Non-allergic asthma (mode)

235

1199

1.96

20.60

2.9

2.5

—

Acute posthaemorrhagic anaemia

223

3.45

20.58

3.8

4.3

—

Disorders of sclera, cornea, iris and ciliary body

745

5175

1.45

20.31

3.1

3.4

—

Pain in thoracic spine

208

1035

2.04

20.24

3.9

3.1

—

Other crystal arthropathies

142

4.20

20.22

3.2

4.0

—

Open wound of lower leg

230

1188

1.97

20.17

2.9

3.4

—

Protein-energy malnutrition of moderate and mild degree

6.82

20.14

2.2

3.2

—

Intracranial injury

811

5420

1.42

19.95

3.3

—

Unspecified fall

721

4928

1.45

19.79

3.1

3.2

—

Familial hypercholesterolemia

260

1412

1.87

19.64

3.5

3.2

—

Other embolism and thrombosis

213

1083

2.00

19.62

3.8

3.5

—

Other symptoms and signs involving the digestive system and abdomen

244

1299

1.91

19.53

3.7

3.2

—

Visual disturbances and blindness

738

5156

1.44

19.51

3.3

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

158

3.84

19.50

1.8

3.0

—

Vitamin B12 deficiency anaemia

194

958

2.07

19.44

2.6

3.5

—

Unstable angina pectoris

606

3201

1.51

19.40

2.8

3.6

—

Infection of intervertebral disc (pyogenic)

4.94

19.32

2.0

4.0

—

Injuries to the elbow and forearm

914

5818

1.39

19.28

2.9

3.4

—

Other disorders of bladder

217

1119

1.98

19.26

2.5

3.6

—

Cardiac arrest

292

2.87

19.26

2.0

3.2

—

Disorders of the thyroid gland

1277

6301

1.33

19.12

3.2

3.4

—

Systemic lupus erythematosus, unspecified

175

3.69

19.10

1.5

4.0

—

Collapsed vertebra, not elsewhere classified

6.66

19.01

11.0

4.5

—

799

5132

1.42

18.93

2.1

3.4

—

Polyarteritis nodosa and related conditions

5.45

18.91

1.8

4.8

—

Malignant neoplasm of urinary organs

170

808

2.15

18.90

2.4

1.5

—

Allergic asthma (mode)

205

1016

1.99

18.83

2.4

2.3

—

Pyothorax

369

2.76

18.55

3.6

3.7

—

Other or ill-defined heart diseases

295

2.95

18.55

2.0

3.0

—

Injuries to the knee and lower leg

1571

6801

1.29

18.43

2.8

3.4

—

Seropositive rheumatoid arthritis, strict definition

240

1298

1.88

18.40

2.0

3.4

—

5-aminosalicylic acid

231

1232

1.89

18.33

2.6

3.8

—

Tumor necrosis factor alpha inhibitors

176

855

2.08

18.32

2.2

3.6

—

Injury, poisoning and certain other consequences of external causes

656

2221

1.49

18.31

3.5

—

Secondary right heart disease

366

2.76

18.30

2.2

3.4

—

Other condition

201

1027

1.99

18.24

3.2

3.5

—

Soft tissue disorders related to use, overuse and pressure

390

2418

1.63

18.23

2.6

3.7

—

Other pulmonary heart/vessel disease

104

407

2.65

18.23

2.2

3.5

—

Drug-induced neutropenia

132

576

2.36

18.17

3.4

4.1

—

Degeneration of macula and posterior pole

821

4693

1.41

18.14

2.8

3.5

—

Other obstructive and reflux uropathy

195

3.42

18.14

1.6

3.8

—

Duodenal ulcer

202

1038

1.99

18.13

2.0

3.6

—

Vitreous haemorrhage

175

857

2.09

18.00

2.4

3.7

—

Other complications of surgical and medical care, not elsewhere classified

149

685

2.22

17.99

3.7

3.5

—

Amputation of ankle bones

174

3.64

17.89

2.8

3.6

—

Unspecified contracted kidney

8.62

17.80

1.6

5.0

—

Acute nephritic syndrome

128

4.10

17.77

3.1

4.6

—

Rotator cuff syndrome

857

4447

1.39

17.76

2.9

3.7

—

Diseases of the ear and mastoid process

1485

5787

1.29

17.76

3.5

3.2

—

Benign neoplasm: Colon, unspecified

433

2774

1.58

17.76

3.0

3.4

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

26.60

17.67

2.4

8.7

—

Other diseases of pancreas

153

718

2.19

17.66

2.9

3.5

—

Substance abuse, excluding more controls

729

4396

1.42

17.64

2.1

3.5

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

360

2184

1.65

17.51

3.6

1.6

—

Other and unspecified coagulation defects

300

2.88

17.48

3.0

3.8

—

Disorders of synovium and tendon

661

4033

1.44

17.48

2.5

3.8

—

Acute peritonitis

124

536

2.38

17.47

2.8

3.8

—

Acidosis

149

3.82

17.32

2.3

4.0

—

Bronchiectasis

157

751

2.15

17.29

2.7

3.7

—

Vitamin D deficiency

4.66

17.26

1.8

3.9

—

Other chronic obstructive pulmonary disease, including avohilmo

880

5336

1.37

17.17

2.0

3.5

—

Malignant neoplasm of kidney, except renal pelvis

153

726

2.16

17.14

2.3

1.5

—

Fluid overload

17.33

17.09

3.3

4.5

—

819

5240

1.39

17.05

2.1

3.4

—

Benign neoplasm of other and ill-defined parts of digestive system

295

1736

1.73

17.03

3.0

3.4

—

Alcoholic liver disease

175

876

2.04

16.99

1.4

3.6

—

Inflammatory bowel disease

392

2475

1.60

16.99

2.5

3.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1218

6120

1.31

16.98

3.3

3.4

—

Drug-induced osteoporosis

4.78

16.94

1.5

4.9

—

Diabetic maculopathy

243

1276

1.84

16.91

1.8

2.8

—

Fitting and adjustment of other devices

544

3330

1.49

16.76

3.7

3.1

—

Mycoses

1088

7192

1.32

16.72

3.2

3.4

—

Hypothyroidism, other/unspecified

1171

5882

1.32

16.69

3.3

3.4

—

L04AC Interleukin inhibitors

313

2.78

16.68

1.9

3.6

—

Polyuria

358

2228

1.63

16.61

2.4

3.6

—

Disturbances of skin sensation

326

1980

1.66

16.56

3.2

3.3

—

Mixed hyperlipidaemia

288

2.87

16.49

1.7

3.9

—

Other and unspecified drugs and medicaments

137

632

2.21

16.48

5.2

3.5

—

Other renal tubulo-interstitial diseases

108

4.22

16.48

1.7

3.9

—

Ulcerative colitis

307

1839

1.69

16.47

2.7

3.3

—

Disorder of lipoprotein metabolism, unspecified

215

1166

1.88

16.41

2.4

3.3

—

Hypersplenism

15.22

16.40

2.1

4.5

—

Infarction of spleen

6.84

16.34

1.3

5.0

—

Alcohol use disorder, Swedish definition

750

4968

1.39

16.28

2.0

3.4

—

Mood disorders, excluding more controls

1214

5573

1.31

16.19

2.9

3.5

—

Artificial joint operation, meniscal resection

1322

6694

1.29

16.11

3.1

3.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1098

5647

1.32

16.08

3.3

3.4

—

Other nutritional anaemias

5.37

16.00

1.5

4.1

—

Other and unspecified local infections of skin and subcutaneous tissue

146

699

2.13

15.97

4.7

3.7

—

Delirium, not induced by alcohol and other psychoactive substances

229

1277

1.83

15.94

2.6

3.2

—

Herpesviral [herpes simplex] infections

162

807

2.04

15.89

4.4

3.5

—

Juvenile arthritis (FINNGEN)

133

3.75

15.88

2.1

4.7

—

Functional dyspepsia

348

2173

1.62

15.87

3.7

3.5

—

Other local infections of skin and subcutaneous tissue

153

748

2.08

15.82

4.6

3.6

—

Urticaria and erythema

419

2731

1.55

15.79

4.2

3.2

—

Other symptoms and signs involving the circulatory and respiratory systems

399

2.51

15.71

3.1

3.5

—

Hepatic failure, not elsewhere classified

285

2.84

15.69

1.9

3.8

—

Gonarthrosis,primary

1331

6419

1.28

15.64

3.2

3.5

—

Essential (haemorrhagic) thrombocythaemia

248

2.96

15.49

3.2

1.4

—

COPD related to multimorbidity

682

4139

1.41

15.29

2.0

3.5

—

Unknown and unspecified causes of morbidity

374

2.53

15.29

3.0

3.3

—

Polycystic ovarian syndrome, consortium definition

742

3167

1.39

15.26

3.3

3.4

—

Reactive arthropathies

120

541

2.26

15.26

2.6

4.1

—

Intestinal malabsorption

300

2.74

15.25

2.1

4.2

—

Visual disturbances

660

4737

1.40

15.17

3.5

3.3

—

Acute bronchiolitis

113

3.79

15.13

9.4

2.4

—

Aortic aneurysm

394

2521

1.55

14.94

3.0

3.4

—

Irritable bowel syndrome

321

1997

1.62

14.87

2.9

3.4

—

Acute generalized exanthematous pustulosis

299

2.72

14.82

6.0

4.2

—

Polyarthritis, unspecified

227

3.00

14.80

2.1

4.1

—

Thiazolidinediones

195

1062

1.87

14.79

2.1

3.9

—

Combinations of oral blood glucose lowering drugs

424

2817

1.52

14.78

2.3

3.9

—

Anosmia

5.83

14.73

3.3

1.8

—

Other juvenile arthritis

117

3.83

14.71

2.2

4.1

—

Intestinal stricture

487

3330

1.48

14.71

3.2

—

Other symptoms and signs involving cognitive functions and awareness

710

4716

1.38

14.64

2.7

3.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

203

1087

1.83

14.55

2.3

3.4

—

Non-selective monoamine reuptake inhibitors

539

3623

1.45

14.53

2.6

3.5

—

Coxarthrosis, primary

951

6136

1.32

14.51

2.8

3.5

—

Traumatic subdural haemorrhage

233

1289

1.76

14.48

3.2

3.6

—

Spondylolisthesis/Spondylolysis

251

1479

1.72

14.45

3.7

3.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

190

998

1.87

14.42

2.3

3.6

—

Crohn disease

156

794

1.99

14.41

1.7

3.7

—

Benign neoplasm of other and unspecified endocrine glands

199

1100

1.84

14.36

2.8

3.5

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

486

2844

1.48

14.30

2.1

3.4

—

Benign neoplasm: Transverse colon

192

1054

1.86

14.26

3.1

3.7

—

Thyroiditis, ILD-related definition

137

669

2.08

14.22

3.1

3.5

—

Nonalcoholic fatty liver disease

136

664

2.08

14.17

2.4

4.0

—

Cyst of kidney

132

640

2.12

14.13

3.8

—

Etanercept

353

2.51

14.10

2.4

3.9

—

Pyoderma gangrenosum

6.68

13.97

2.7

5.8

—

COPD, hospital admissions

747

4675

1.36

13.96

2.0

3.5

—

COPD, early/later onset

755

4718

1.36

13.96

2.0

3.5

—

Kela reimbursement Agammaglobulinemia (D80-84)

6.63

13.94

7.7

5.6

—

Recurrent and persistent haematuria

6.07

13.89

2.7

4.3

—

Other diseases of stomach and duodenum

114

526

2.22

13.83

2.2

3.8

—

Abnormalities of gait and mobility

207

1174

1.80

13.78

2.3

3.5

—

Generalized skin eruption due to drugs and medicaments

259

2.78

13.76

6.2

4.3

—

Drug-induced cataract

153

3.41

13.74

5.0

4.3

—

Superficial injury of hip and thigh

227

1321

1.74

13.71

2.3

3.2

—

Polycythaemia vera

232

2.90

13.69

2.8

1.4

—

Anxiety disorders, excluding more controls

991

4951

1.31

13.66

3.3

3.6

—

Ankylosing spondylitis

117

547

2.17

13.65

1.9

3.4

—

Open wound of ankle and foot

142

716

2.01

13.55

3.1

3.5

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

427

2893

1.49

13.52

3.2

3.4

—

Psoriatic arthropathies

131

642

2.07

13.51

2.0

4.0

—

COPD, hospital admission 2, with asthma infections

545

3306

1.43

13.48

2.1

3.4

—

Other disorders of veins

536

3774

1.42

13.38

2.6

3.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

252

1510

1.67

13.34

2.9

3.3

—

Viral and other specified intestinal infections

184

989

1.83

13.28

4.1

2.8

—

Diseases of peritoneum

163

869

1.91

13.26

2.4

3.5

—

Spontaneous rupture of synovium and tendon

130

641

2.07

13.25

2.4

3.8

—

Wegener granulomatosis

4.10

13.18

2.0

5.6

—

COPD-related respiratory insufficiency

218

1272

1.75

13.18

1.9

3.5

—

Viral warts

122

588

2.11

13.17

2.7

3.8

—

Chronic myeloproliferative disease

100

4.04

13.16

4.9

4.3

—

Cardiac murmurs and other cardiac sounds

102

452

2.26

13.14

4.1

3.2

—

Emphysema

137

693

2.02

13.07

2.4

3.9

—

Exclusions for E4_PCOS_CONSORTIUM

764

3563

1.35

13.02

3.3

3.2

—

Adalimumab

107

492

2.21

13.01

1.8

3.9

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

126

619

2.08

13.00

3.3

3.5

—

Pain associated with micturition

165

889

1.88

12.96

3.4

3.5

—

Superficial injury of lower leg

302

1918

1.59

12.93

2.6

3.4

—

689

4687

1.36

12.91

3.9

3.3

—

Neuralgia and neuritis, unspecified

321

2.52

12.84

4.3

3.9

—

Sequelae of cerebrovascular disease

600

3757

1.39

12.80

2.4

3.4

—

Dilated cardiomyopathy

203

1171

1.77

12.79

2.3

3.6

—

Mental and behavioural disorders due to psychoactive substance use

762

5319

1.33

12.78

2.0

3.4

—

Scoliosis

104

477

2.21

12.75

2.9

3.3

—

Other disorders of nervous system

114

544

2.14

12.74

3.2

3.9

—

Benign neoplasm: Adrenal gland

131

659

2.03

12.71

2.7

3.8

—

Late syphilis

4.06

12.59

2.4

4.3

—

Sequelae of other external causes

399

2.33

12.51

3.0

3.8

—

Cervical disc disorders

468

3278

1.44

12.48

3.0

3.3

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

201

1161

1.75

12.45

2.9

1.5

—

Asthma and allergy, excluding more controls

368

2.35

12.41

3.0

2.0

—

Hyperplasia of prostate

564

2286

1.41

12.38

3.5

—

Abnormal serum enzyme levels

456

3104

1.45

12.37

2.8

3.4

—

Late syphilis

114

3.69

12.33

2.2

3.9

—

Acute myeloid leukaemia

5.50

12.17

1.1

1.2

—

Acute myeloid leukaemia, helper endpoint

5.50

12.17

1.1

1.2

—

Acute myeloid leukaemia, including Hilmo

5.50

12.17

1.1

1.2

—

Barrett oesophagus

418

2.29

12.14

2.8

4.2

—

Disorders of skin appendages

530

3811

1.40

12.05

3.0

3.3

—

Benign neoplasm: Ascending colon

232

1411

1.67

12.04

3.2

3.5

—

Mantle cell lymphoma, including Hilmo

4.07

12.02

2.1

1.3

—

Artrosis, including avohilmo

1081

4658

1.28

12.01

2.7

3.6

—

Varicose veins

884

5162

1.30

11.99

3.2

3.4

—

Lichen simplex chronicus and prurigo

100

465

2.20

11.95

3.2

4.1

—

Artificial joint re-operation

128

654

2.01

11.95

2.0

3.4

—

Ulcerative colitis, NAS

165

912

1.83

11.94

2.5

3.6

—

Postzoster neuralgia

107

3.73

11.92

4.4

4.1

—

Carpal tunnel syndrome

790

5324

1.31

11.90

3.5

—

Idiopathic pulmonary fibrosis

148

795

1.91

11.89

2.3

3.5

—

Carrier of infectious disease

131

3.39

11.89

1.6

4.0

—

Secondary thrombocytopenia

4.23

11.86

7.5

4.4

—

Herpesviral [herpes simplex] infections

263

1651

1.61

11.86

4.0

3.1

—

Other blood glucose lowering drugs, excl. Insulins

258

1617

1.62

11.83

2.4

3.6

—

Reactive arthropathies, FINNGEN

384

2.30

11.75

3.1

4.4

—

Haemorrhoids and perianal venous thrombosis

448

3145

1.43

11.70

3.2

3.3

—

Hodgkin lymphoma, hilmo

174

3.02

11.69

2.1

4.2

—

Crohn's disease NAS

360

2.35

11.69

1.7

3.8

—

Internal derangement of knee

409

2815

1.45

11.67

3.1

3.9

—

Acute suppurative otitis media

195

1058

1.73

11.66

4.8

3.2

—

Leukaemia of unspecified cell type

4.80

11.64

4.6

3.6

—

Secondary systemic amyloidosis

13.32

11.63

8.0

5.6

—

Other hearing loss

449

3099

1.43

11.58

3.4

3.2

—

Benign neoplasm: Caecum

182

1050

1.77

11.53

3.4

3.5

—

Acute gastritis

119

600

2.02

11.48

3.5

3.8

—

Mucosal proctocolitis

143

766

1.89

11.45

2.5

3.8

—

Asthma and opportunity respiratory infection

416

2.25

11.45

2.4

3.8

—

Conjunctivitis (acute, non atopic)

316

2079

1.53

11.41

4.7

3.1

—

Other and unspecified haemorrhagic conditions

3.81

11.39

2.8

3.9

—

Lung cancer and mesothelioma

257

1382

1.61

11.38

2.4

2.7

—

Presbycusis

258

1618

1.60

11.37

2.8

3.0

—

ILD-related respiratory insufficiency

311

2.47

11.37

2.9

3.9

—

Dermatopolymyositis (FG)

4.16

11.36

5.5

6.4

—

Actinic keratosis

641

4447

1.35

11.35

4.1

3.2

—

Diplopia

190

1115

1.73

11.27

2.9

3.4

—

Skin changes due to chronic exposure to nonionizing radiation

652

4522

1.34

11.26

4.0

3.3

—

Contact with and exposure to communicable diseases

226

1378

1.64

11.24

4.4

3.2

—

Substance abuse

729

5236

1.31

11.13

2.1

3.4

—

Malignant neoplasm of endocrine gland

413

2.22

11.11

3.8

1.4

—

Disorders of muscles

132

698

1.92

11.05

2.2

3.5

—

Other viral diseases, not elsewhere classified

252

1585

1.59

11.02

5.2

3.2

—

Drug-induced polyneuropathy

4.59

11.00

16.0

3.9

—

Corns and callosities

104

508

2.09

10.98

4.3

3.6

—

Malignant neoplasm, without specification of site, including Hilmo

352

2.32

10.96

3.0

1.4

—

Cryoglobulinemia

24.61

10.95

6.8

1.4

—

Selective serotonin reuptake inhibitors

1285

5446

1.24

10.88

3.0

3.5

—

Other viral diseases, not elsewhere classified

194

1152

1.69

10.84

5.9

3.3

—

Lung diseases due to external agents

229

1426

1.63

10.84

2.6

3.3

—

515

3271

1.38

10.82

2.6

3.3

—

Oesophagitis

445

2.16

10.80

2.1

3.9

—

Stomatitis and related lesions

237

1488

1.61

10.77

3.6

3.3

—

Substance use, excluding alcohol

208

1264

1.66

10.76

2.0

3.6

—

Gangrene, not elsewhere classified

5.12

10.68

4.0

5.6

—

Gingival hyperplasia

223

2.67

10.66

3.5

4.1

—

Speech therapy

372

2579

1.46

10.63

2.5

3.3

—

Glaucoma

858

5796

1.28

10.62

3.3

—

Recurrent aphthous stomatitis , including avohilmo

180

1059

1.72

10.58

3.4

3.3

—

Other disorders of glucose regulation and pancreatic internal secretion

117

604

1.97

10.56

1.6

3.4

—

Other diseases of upper respiratory tract

1466

6308

1.22

10.54

3.2

3.3

—

Tobacco use

334

2.32

10.46

2.1

3.8

—

Fracture of forearm

679

4749

1.32

10.45

3.0

3.5

—

Squamous cell neoplasms and carcinomas of the skin

137

748

1.86

10.44

2.4

1.5

—

Other diseases of lip and oral mucosa

508

3726

1.37

10.44

3.9

3.3

—

Unspecified privation

146

813

1.82

10.42

3.7

3.5

—

Other and unspecified nerve root and plexus disorders, also in other diseases

246

1573

1.58

10.37

3.0

3.3

—

Gonarthrosis, primary, with knee surgery

880

5529

1.28

10.37

2.8

3.5

—

Inflammatory diseases of the central nervous system

110

560

2.00

10.34

3.1

3.6

—

Calcinosis cutis

24.74

10.31

6.6

1.7

—

Rash and other nonspecific skin eruption

134

730

1.86

10.29

2.2

3.5

—

Chronic sinusitis

514

3782

1.37

10.27

3.2

3.5

—

Superficial injury of head

307

2063

1.50

10.27

2.3

3.1

—

Poisoning by drugs, medicaments and biological substances

227

1427

1.60

10.25

3.0

3.2

—

Somatoform disorder

187

1121

1.68

10.24

3.2

3.4

—

Malignant neoplasm of thyroid gland, including Hilmo

447

2.11

10.24

3.8

1.4

—

Alcohol-induced chronic pancreatitis

489

2.07

10.18

2.2

4.0

—

Diseases of salivary glands

392

2766

1.43

10.16

3.1

3.3

—

Hallux valgus (acquired)

380

1900

1.45

10.14

3.1

3.9

—

Diseases of male genital organs

666

2536

1.33

10.14

3.0

3.4

—

Other ill-defined and unspecified causes of mortality

145

815

1.82

10.14

3.0

3.2

—

Ankylosing spondylitis, ICD10

112

578

1.97

10.13

1.9

3.8

—

Cholecystitis

218

1365

1.62

10.11

3.3

3.2

—

Personality disorders, excluding more controls

214

1330

1.62

10.10

2.3

3.5

—

Asthma and allergy

403

2.14

10.07

3.0

2.2

—

Covid-19 suspected case

212

1317

1.62

10.07

2.6

3.3

—

Cachexia

9.54

10.06

2.7

3.4

—

IBD patients in KELA-register

241

1545

1.57

10.03

2.6

3.4

—

Vascular diseases of the intestine

335

2.30

10.01

2.8

3.3

—

Acquired absence of limb

4.48

10.00

2.2

5.1

—

Primary biliary cholangitis (PBC)

125

3.22

10.00

1.4

4.1

—

Malignant neoplasm of other connective and soft tissue

157

2.96

9.99

6.7

1.4

—

Encephalitis

168

2.87

9.95

2.9

3.9

—

Syphilis

174

2.85

9.93

2.1

4.0

—

Syphilis

174

2.85

9.93

2.1

4.0

—

Neuromuscular dysfunction of bladder

134

740

1.84

9.88

2.4

3.9

—

Seborrhoeic dermatitis

134

741

1.84

9.83

3.3

3.7

—

Superficial injury of abdomen, lower back and pelvis

175

1043

1.69

9.82

2.7

3.4

—

Bipolar affective disorders

173

1027

1.70

9.82

2.1

3.6

—

Disorders of oesophagus in diseases classified elsewhere

170

2.88

9.82

3.3

4.2

—

Dermatopolymyositis

3.72

9.79

5.5

5.6

—

Psoriasis vulgaris

239

1540

1.57

9.79

2.2

3.4

—

Psoriasis (vulgaris), strict definition

198

2.69

9.77

1.6

3.9

—

Other bursopathies

182

1099

1.68

9.76

4.2

3.7

—

Explicit fungal Sepsis

5.35

9.75

1.5

3.4

—

Other abnormal findings in urine

112

3.36

9.74

3.9

3.0

—

Viral and other specified intestinal infections

230

1414

1.58

9.74

4.0

2.8

—

Endocrine disorders, other/unspecified

117

3.27

9.71

3.0

4.6

—

Psoriasis

360

2524

1.44

9.71

2.2

3.3

—

Status post-ami

402

2179

1.42

9.66

2.3

3.4

—

Clear cell adenocarcinoma of kidney

321

2.30

9.65

2.4

1.5

—

Other encephalitis

160

2.89

9.64

3.0

3.8

—

Malignant neoplasm of thyroid gland

385

2.17

9.62

4.0

1.4

—

Paracetamol or NSAID medication

169

486

1.76

9.62

3.9

2.7

—

Mood [affective] disorders

1240

6616

1.22

9.57

2.8

3.5

—

Benign neoplasm: Sigmoid colon

295

2000

1.49

9.57

3.1

3.5

—

Mood disorders

1243

6624

1.22

9.55

2.8

3.5

—

Congenital malformations, deformations and chromosomal abnormalities

588

4253

1.32

9.47

2.6

3.3

—

Abnormal involuntary movements

177

1073

1.67

9.37

3.4

3.5

—

Mental and behavioural disorders due to alcohol

640

4738

1.30

9.37

2.0

3.4

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

353

1347

1.46

9.34

3.0

3.2

—

Other specified/unspecified inflammatory spondylopathies

214

2.56

9.32

2.5

3.7

—

Other general symptoms and signs

206

2.58

9.31

1.8

3.5

—

Coronary artery bypass grafting

402

2144

1.41

9.30

2.0

3.5

—

Other headache syndromes

458

3365

1.37

9.28

3.2

3.7

—

Viral warts

220

1411

1.57

9.19

3.1

3.2

—

Acquired pure red cell aplasia [erythroblastopenia]

8.83

9.16

2.6

3.0

—

Injuries to unspecified part of trunk, limb or body region

138

787

1.78

9.16

1.9

3.5

—

Need for other prophylactic measures

414

2.09

9.12

1.8

3.7

—

Malignant neoplasm of bladder, including Hilmo

175

1059

1.66

9.11

2.8

1.5

—

Persons encountering health services for specific procedures, not carried out

447

2.04

9.10

2.6

3.4

—

Respiratory disorders in diseases classified elsewhere

107

3.34

9.08

2.5

4.3

—

Inflammatory bowel disease, strict (require KELA)

241

1583

1.53

9.05

2.6

3.4

—

Anxiety disorders

1011

5723

1.23

9.03

3.3

3.5

—

Other/unspecified crystal arthropathies

5.02

9.02

3.6

3.8

—

Use of pramipexole

319

2222

1.45

9.00

2.7

3.5

—

Other abnormal immunological findings in serum

3.55

9.00

4.4

4.3

—

Disorders of magnesium metabolism

4.14

8.91

1.2

4.0

—

Pulmonary oedema

140

2.97

8.88

4.2

4.0

—

Depression

1120

6240

1.22

8.87

2.9

3.5

—

Iron deficiency

3.66

8.87

1.6

4.8

—

Olecranon bursitis

480

1.99

8.87

2.5

3.7

—

Other nonthrombocytopenic purpura

4.33

8.86

2.2

4.3

—

Other localized connective tissue disorders

124

3.09

8.85

4.5

4.4

—

Viral hepatitis

378

2.12

8.85

2.4

3.4

—

Artificial opening status

440

2.04

8.83

3.2

3.5

—

Other chondrocalcinosis

104

3.35

8.82

3.0

4.0

—

Other inflammation of eyelid

180

1114

1.63

8.82

3.9

3.4

—

Monoarthritis, not elsewhere classified

251

2.40

8.81

1.8

4.5

—

Mature T/NK-cell lymphomas, hilmo

104

3.33

8.80

1.5

4.6

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

169

2.76

8.79

1.8

3.7

—

Other shoulder lesions

109

586

1.88

8.77

2.0

3.7

—

Polyarteritis nodosa

7.38

8.73

1.6

6.9

—

Ill-defined and unknown causes of mortality

150

890

1.72

8.72

3.2

3.3

—

Total colectomy operation

265

2.35

8.71

3.5

4.3

—

Total colectomy

265

2.35

8.71

3.5

4.3

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

4.75

8.70

7.3

1.3

—

Chronic myeloid leukaemia, including Hilmo

4.97

8.70

1.4

1.2

—

Visual impairment including blindness (binocular or monocular)

108

582

1.89

8.69

1.8

3.0

—

Neurotic, stress-related and somatoform disorders

992

5652

1.23

8.68

3.3

3.4

—

In situ neoplasms

529

4023

1.32

8.65

4.1

3.2

—

Nummular dermatitis

116

640

1.84

8.65

3.1

3.8

—

Other endocrine disorders

195

2.54

8.62

3.0

4.1

—

Congenital malformations, deformations and chromosomal abnormalities

655

4713

1.29

8.58

2.5

3.3

—

Other Crohn's disease

357

2.13

8.53

1.7

3.4

—

Retinal vascular occlusion

200

1282

1.58

8.52

2.9

3.4

—

Lupus nephritis

11.78

8.51

1.3

8.3

—

Renal agenesis and other reduction defects of kidney

9.17

8.49

1.4

5.3

—

Exposure to other specified factors

860

6374

1.24

8.49

3.0

3.4

—

Papulosquamous disorders

501

3793

1.33

8.45

2.6

3.4

—

Thrombotic microangiopathy

7.58

8.45

3.4

5.3

—

Fracture of lower leg, including ankle

678

5283

1.28

8.45

2.5

3.5

—

Other symptoms and signs involving the urinary system

150

898

1.69

8.41

3.4

3.8

—

Diseases of external ear

432

3203

1.36

8.41

3.7

3.2

—

Arterial embolism and thrombosis of lower extremity artery

315

2.22

8.38

2.7

3.9

—

Radiculopathy

220

1444

1.54

8.38

3.4

3.2

—

Other specified disorders of kidney and ureter

239

2.41

8.37

2.1

4.2

—

Other sleep disorders

141

832

1.71

8.32

2.4

4.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

167

1029

1.64

8.32

3.0

3.5

—

Aortic valve malfunction, age under 60 years

114

634

1.82

8.28

3.0

3.8

—

Coxarthrosis, primary, with hip surgery

720

5358

1.27

8.26

2.8

3.5

—

Arthropathic psoriasis

142

843

1.71

8.21

1.8

3.8

—

Ulcerative colitis (strict definition, require KELA)

172

1074

1.61

8.12

3.0

3.5

—

Prurigo nodularis

176

2.64

8.11

2.2

5.1

—

Bacterial, viral and other infectious agents

495

1.92

8.10

3.1

3.5

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

4.01

8.09

3.6

1.2

—

Fissure and fistula of anal and rectal regions

283

1967

1.45

8.09

3.4

3.3

—

Disorders of parathyroid gland, other and/or unspecified

4.22

8.07

1.7

4.7

—

Personal history of other diseases and conditions

417

2.00

8.04

5.6

3.4

—

Need for immunization against other single viral diseases

115

3.05

8.02

3.7

3.6

—

Retinal vascular disorders

201

1309

1.56

8.01

2.9

3.4

—

Coxibs

373

1410

1.40

7.99

2.8

3.1

—

Carcinoma in situ of skin of scalp and neck

258

2.34

7.98

3.5

3.6

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

118

671

1.78

7.96

2.9

3.7

—

Migraine without aura

138

818

1.70

7.96

4.1

3.6

—

Malignant neoplasm of prostate, including Hilmo

398

1727

1.38

7.94

2.8

1.5

—

Other and unspecified tonsillitis

244

1382

1.49

7.94

3.2

2.7

—

Systemic sclerosis (FG)

132

2.88

7.93

2.0

4.9

—

Trochanteric bursitis

180

1145

1.59

7.91

3.0

3.8

—

Primary gonarthrosis, bilateral

747

5130

1.25

7.89

2.7

3.5

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

3.25

7.89

1.7

4.2

—

Cervicalgia

244

1657

1.48

7.89

2.8

3.2

—

Flat foot [pes planus] (acquired)

111

622

1.81

7.87

2.2

4.4

—

Transient ischemic attack

782

5099

1.25

7.87

2.9

3.5

—

Cardiomyopathy, Hypertrophic obstructive

111

3.07

7.87

2.3

4.1

—

Seborrhoeic keratosis

321

2297

1.41

7.86

4.0

3.4

—

Hyperaldosteronism

209

2.46

7.86

1.7

4.3

—

Special screening examination for other diseases and disorders

126

732

1.74

7.85

2.4

3.2

—

Hepatocellular carcinoma, including Hilmo

209

2.46

7.85

2.2

1.4

—

Bacterial, viral and other infectious agents

529

1.87

7.84

3.1

3.5

—

Abnormal spermatozoa

205

1349

1.54

7.83

3.0

3.5

—

Listeriosis

7.30

7.82

10.5

7.4

—

Disorders of conjunctiva

933

6144

1.22

7.82

3.6

3.3

—

Other diseases of oesophagus

140

840

1.69

7.82

2.6

3.6

—

Other diseases of biliary tract

130

765

1.72

7.82

2.9

3.3

—

Other abnormal uterine and vaginal bleeding

272

1341

1.46

7.81

3.5

3.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

185

1187

1.57

7.81

2.9

3.4

—

Injuries to the ankle and foot

729

5186

1.25

7.80

3.0

3.4

—

Other disorders of the musculoskeletal system and connective tissue

199

1301

1.55

7.77

2.9

3.5

—

Scabies

116

661

1.77

7.74

2.8

3.5

—

Arterial embolism and thrombosis

540

1.87

7.72

2.5

3.5

—

Other viral hepatitis

292

2.19

7.70

2.6

3.4

—

Coeliac disease

139

835

1.68

7.70

3.8

3.7

—

Urticaria

293

2068

1.42

7.70

4.7

3.2

—

Malignant neoplasm, without specification of site

236

2.34

7.67

2.9

1.3

—

Respiratory conditions due to other external agents

152

2.72

7.67

4.1

3.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

252

1731

1.46

7.66

2.9

3.1

—

Lesion of lateral popliteal nerve

361

2.06

7.60

4.2

3.6

—

Acute lymphadenitis

307

2.15

7.60

2.6

3.7

—

Suicide or other Intentional self-harm

235

1596

1.48

7.59

2.9

3.2

—

Early complications of trauma

275

2.22

7.59

2.6

3.6

—

!Aliquae complicationes praecoces traumatis

275

2.22

7.59

2.6

3.6

—

Open wound of forearm

115

659

1.77

7.58

2.5

3.4

—

Adverse effects, not elsewhere classified

198

1300

1.53

7.55

3.0

3.3

—

Other and unspecified mononeuropathies, also in other diseases

213

2.41

7.54

2.5

3.9

—

Orchitis and epididymitis

132

788

1.70

7.53

3.4

3.3

—

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

25.16

7.52

6.1

4.0

—

Poisoning by medicine

193

1262

1.54

7.48

2.7

3.3

—

Phobic anxiety disorders

507

1.86

7.48

2.9

3.5

—

Hypersensitivity angiitis

6.77

7.46

1.6

4.1

—

Amiodarone users

162

1023

1.61

7.44

2.7

3.6

—

malignant neoplasm of male genital organs

384

1719

1.37

7.43

2.7

1.5

—

Myositis

172

2.57

7.42

2.2

3.7

—

Other nonautoimmune haemolytic anaemias

12.00

7.41

9.5

1.5

—

Primary adrenocortical insufficiency

3.75

7.41

1.2

5.2

—

Mantle cell lymphoma

4.02

7.38

1.2

—

Other psoriatic arthropathies

124

733

1.71

7.34

2.0

4.0

—

6-mercaptopurine

3.07

7.33

1.7

4.5

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

550

4281

1.29

7.33

1.9

3.4

—

Infection due to other mycobacteria

100

3.10

7.29

1.7

4.5

—

Other anxiety disorders

388

2501

1.35

7.27

2.4

3.3

—

Renal agenesis and other reduction defects of kidney

8.51

7.27

1.4

5.5

—

Viral infections of the central nervous system

443

1.92

7.26

2.6

3.5

—

Lesion of ulnar nerve

171

1098

1.57

7.26

2.8

3.4

—

Other follicular disorders

415

1.95

7.26

2.0

3.7

—

Impacted cerumen

147

912

1.63

7.25

3.2

3.4

—

Other and unspecified psoriasis

515

1.85

7.25

1.5

3.9

—

Other/unspecified synovitis and tenosynovitis

137

834

1.66

7.25

2.0

3.6

—

Other immunodeficiencies

4.07

7.24

5.6

5.3

—

Benign neoplasm of urinary organs

396

1.99

7.22

2.0

3.8

—

Other hammer toe(s) (acquired)

215

1336

1.50

7.22

2.5

4.0

—

Benign neoplasm: Duodenum

237

2.31

7.22

2.8

4.0

—

Wet age-related macular degeneration

296

2059

1.41

7.20

2.4

3.1

—

Psoriatic arthropathies, ICD10

127

760

1.69

7.19

2.0

4.0

—

Benign neoplasm: Stomach

145

899

1.64

7.19

3.3

3.5

—

Central retinal artery occlusion

188

2.47

7.14

4.6

3.4

—

Hypopituitarism

397

1.96

7.11

3.1

3.6

—

Abnormal findings in nipple discharge synovial fluid wound secretions

3.18

7.11

2.9

4.0

—

Hyperhidrosis

112

2.90

7.09

2.4

4.0

—

Disorders of vitreous body and globe

702

5448

1.24

7.08

3.6

3.5

—

Right bundle-branch block

238

2.27

7.08

2.9

3.4

—

Fibrosis of liver

4.60

7.07

1.5

3.8

—

Asthma mixed form (mode), excluding more controls

231

2.28

7.07

1.7

2.3

—

Mental and behavioural disorders due to sedatives or hypnotics

364

2.00

7.04

1.6

3.4

—

Chronic viral hepatitis

219

2.31

7.03

2.4

3.3

—

Ulcer of oesophagus

108

624

1.76

7.00

3.3

3.8

—

Anxiety (asthma-related co-morbidities)

553

3353

1.28

6.98

2.5

3.5

—

Hypoglycaemia, other or unspecified

464

1.88

6.96

1.5

3.4

—

Unspecified protein-energy malnutrition

6.05

6.94

1.2

4.5

—

Moderate visual impairment, binocular

247

2.24

6.94

1.6

3.4

—

Kyphosis

3.36

6.92

3.8

3.6

—

Other and unspecified effects of external causes

265

1876

1.42

6.91

3.0

3.2

—

Keratitis

409

3103

1.33

6.90

2.8

3.2

—

Malignant neoplasm of prostate

380

1689

1.36

6.87

2.8

1.5

—

Disorders of vitreous body

682

5327

1.24

6.85

3.6

3.5

—

Benign neoplasm: Rectum, anus and anal canal

296

2143

1.39

6.85

3.1

3.4

—

Seronegative juvenile rheumatoid arthritis

4.17

6.84

1.8

3.0

—

Hyperosmolality and hypernatraemia

3.04

6.80

3.0

3.4

—

Dermatopolymyositis, unspecified

6.88

6.80

8.2

8.1

—

Drug-induced hypoglycaemia without coma

3.02

6.78

1.4

4.0

—

Rare circulating lymphoid malignancy

6.30

6.78

4.4

1.3

—

Thyrotoxicosis

292

2111

1.39

6.77

2.8

3.4

—

Carcinoma in situ of skin of other and unspecified parts of face

149

946

1.60

6.76

3.2

3.0

—

Thoracic aortic aneurysm

211

1442

1.48

6.75

3.4

3.6

—

Use of anticholinesterases

355

3725

0.75

6.74

2.1

3.3

—

N06DA Anticholinesterases

355

3725

0.75

6.74

2.1

3.3

—

Benign neoplasm: Rectum

267

1906

1.42

6.73

3.1

3.5

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

4.42

6.68

2.6

4.1

—

Benign neoplasm: Small intestine

366

1.99

6.68

2.5

3.9

—

Oxicams

332

1376

1.38

6.67

3.1

3.2

—

Other overlap syndromes

100

2.99

6.66

1.6

5.4

—

Mastocytosis

7.29

6.66

2.3

3.2

—

Disorders of phosphorus metabolism and phosphatases

6.65

6.64

3.6

—

Other specified/unspecified soft tissue disorders

345

2.00

6.64

2.6

3.8

—

Other mycoses, not elsewhere classified/unspecified

8.12

6.61

4.6

6.3

—

Deficiency of other B group vitamins

146

2.61

6.61

4.9

4.3

—

Disease of hard tissues of teeth, NOS

705

2975

1.24

6.61

3.5

2.8

—

Ovarian cyst

345

1463

1.37

6.60

3.1

3.3

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

285

2.11

6.60

7.1

1.4

—

Secondary polycythaemia

152

2.57

6.59

2.7

4.1

—

Intestinal adhesions without obstruction

114

681

1.70

6.55

3.4

—

Familial hypercholesterolemia, with ischemic heart disease

148

945

1.59

6.54

1.9

3.6

—

Outcome of delivery

363

0.31

6.54

6.4

3.1

—

Colectomy operation

243

1717

1.43

6.51

2.6

3.4

—

Other degenerative diseases of the nervous system

363

2029

1.34

6.50

3.0

3.8

—

5.97

6.50

1.1

5.8

—

Paget disease

5.95

6.49

2.6

5.4

—

Acute drug-induced interstitial lung disorder

3.77

6.44

3.9

5.0

—

Other disorders of iris and ciliary body

197

2.34

6.43

1.6

4.2

—

Migraine

419

2601

1.31

6.43

3.2

3.7

—

Mental and behavioural disorders due to opioids

124

2.70

6.43

2.2

3.5

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

476

3689

1.28

6.41

3.0

3.3

—

Subjective visual disturbances

296

2166

1.38

6.41

3.6

3.4

—

Suppurative and unspecified otitis media

284

1824

1.38

6.37

4.4

3.0

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

4.02

6.37

2.6

4.2

—

Polymyositis

4.01

6.36

3.8

5.4

—

KRA_PSY_EATING, excluding more controls

153

2.48

6.35

2.4

3.1

—

Excessive, frequent and irregular menstruation

362

1477

1.35

6.34

3.3

—

Fracture of neck

546

1.77

6.33

3.7

3.4

—

Fall on and from stairs and steps

314

2324

1.36

6.33

2.7

3.4

—

Crohn's disease of large intestine

283

2.08

6.31

1.6

3.9

—

Abnormality of red blood cells

6.14

6.30

1.6

5.2

—

Acetic acid derivatives and related substances

363

1404

1.35

6.29

3.1

—

Other/unspecified reactive arthropathies

430

1.86

6.27

2.9

3.7

—

Post-traumatic wound infection, not elsewhere classified

168

2.44

6.27

2.0

4.0

—

Atopic dermatitis, strict definition with reimbursement

213

1424

1.45

6.26

2.5

3.3

—

Speech disturbances, not elsewhere classified

130

814

1.62

6.25

2.2

3.3

—

Symptoms and signs involving speech and voice

421

3258

1.30

6.21

3.1

3.3

—

Injury of muscle and tendon at lower leg level

180

1212

1.50

6.21

3.0

3.8

—

Unspecified/other endometriosis

339

1.96

6.19

2.6

3.1

—

Other disorders of bone density and structure

127

2.65

6.18

2.3

4.4

—

Pure hyperglyceridaemia

151

2.51

6.18

2.7

3.4

—

Malignant neoplasm of bone and articular cartilage of limbs

9.18

6.18

6.9

1.0

—

Organic, including symptomatic, mental disorders

785

4621

1.22

6.16

2.6

3.5

—

Febrile neutrophilic dermatosis [Sweet]

17.72

6.15

6.2

9.7

—

Cholangitis (primary sclerosing, PSC)

484

1.80

6.15

1.6

3.2

—

Other specified/unspecified spondylopathies

176

2.39

6.14

4.0

3.5

—

Superficial injury of forearm

565

1.73

6.12

2.7

3.4

—

Chronic hepatitis, not elsewhere classified

221

2.22

6.09

1.5

4.3

—

Other secondary gonarthrosis

428

1.85

6.08

1.5

4.2

—

ILD and respiratory illness in diseases classified elsewhere

5.39

6.04

1.1

5.4

—

Nonsuppurative otitis media

174

1007

1.50

6.03

3.5

3.2

—

Viral infections of the central nervous system

479

1.79

6.03

2.6

3.4

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.85

6.02

1.7

5.5

—

Other ulcerative colitis

330

1.96

5.99

1.9

3.8

—

Primary coxarthrosis, bilateral

429

3348

1.29

5.98

2.2

3.5

—

Fracture of foot, except ankle

243

1742

1.40

5.98

3.3

—

Hernia of abdominal wall

590

4776

1.24

5.97

3.0

3.4

—

347

2474

1.33

5.96

2.8

3.1

—

Primary open-angle glaucoma, strict

404

3124

1.30

5.94

3.6

3.3

—

Inflammatory diseases of female pelvic organs

569

3357

1.25

5.94

2.9

3.5

—

Other and unspecified injuries of lower leg

423

1.84

5.94

2.6

3.7

—

Hypotension due to drugs

113

2.75

5.93

2.8

4.3

—

Adult respiratory distress syndrome

3.05

5.93

4.8

4.6

—

Other or unspecified common variable immunodeficiency

9.94

5.92

1.4

3.3

—

All anxiety disorders

554

3508

1.25

5.91

2.5

3.4

—

Thyrotoxicosis, other and/or unspecified

218

1538

1.43

5.89

2.9

3.3

—

Alcohol-induced acute pancreatitis

251

2.11

5.88

3.3

3.6

—

Other specified/unspecified disorders of bone/cartilage

167

2.39

5.87

3.2

3.8

—

Enteropathic arthropathies

113

2.71

5.87

1.4

4.3

—

Post-traumatic stress disorder

224

2.16

5.84

1.9

3.5

—

Trigger finger

160

1066

1.51

5.83

2.3

3.6

—

Sweet's syndrome

15.16

5.82

6.2

8.7

—

Visual field defects

118

736

1.62

5.80

3.0

3.5

—

220

2.20

5.79

1.8

4.1

—

Systemic sclerosis

156

2.43

5.78

2.0

4.3

—

Asthma mixed form (mode)

252

2.09

5.77

1.7

2.5

—

Allergic bronchopulmonary aspergillosis (ABPA)

8.04

5.75

1.2

3.7

—

Otitis externa, unspecified

115

713

1.63

5.75

4.2

3.6

—

Ventral hernia

319

2405

1.34

5.75

3.1

3.4

—

Other peripheral vascular diseases

100

599

1.69

5.74

1.8

3.6

—

Rosacea

130

831

1.58

5.73

2.8

3.5

—

Other bacterial agents as the cause of diseases classified to other chapters

3.13

5.73

2.4

4.7

—

Other inflammatory liver diseases

480

1.77

5.72

2.0

4.0

—

Other disorders of eyelid

621

4834

1.23

5.71

3.0

3.4

—

Inguinal hernia

767

4259

1.21

5.70

3.6

3.2

—

Any event in hilmo or specialist outpatient

+∞

5.69

1.4

0.0

—

Neovascular glaucoma

316

1.97

5.69

2.6

3.7

—

Actinomycosis

6.97

5.68

1.3

6.1

—

Other and unspecified disorders of skin and subcutaneous tissue

482

1.77

5.65

2.4

3.6

—

Unspecified misadventure during surgical and medical care

446

1.80

5.64

3.3

3.8

—

Congenital malformations and deformations of the musculoskeletal system

471

1.76

5.63

2.0

3.3

—

Non-neuropathic heredofamilial amyloidosis

18.88

5.63

9.0

1.2

—

Complications peculiar to reattachment and amputation

4.00

5.63

1.2

3.1

—

Exfoliative dermatitis

3.11

5.62

2.7

5.0

—

Golimumab

164

2.35

5.62

2.3

3.6

—

Superficial injury of thorax

175

1198

1.47

5.60

2.5

3.3

—

Hypertension, portal

7.73

5.60

1.3

3.1

—

Assault

105

641

1.65

5.58

1.9

3.4

—

Actinomycosis

7.59

5.56

1.3

6.4

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

276

2.01

5.56

1.7

3.3

—

Restrictive cardiomyopathy

6.16

5.56

8.9

4.2

—

Other bacterial agents as the cause of diseases classified to other chapters

3.26

5.55

2.5

4.9

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.75

5.55

1.3

4.4

—

Paralytic ileus

312

1.96

5.55

3.2

—

Other epidermal thickening

312

1.96

5.54

2.8

4.0

—

Presence of other devices

319

2409

1.33

5.53

3.2

—

Abdominal aortic aneurysm (AAA)

164

1104

1.49

5.51

2.4

3.5

—

Background retinopathy and retinal vascular changes

160

2.38

5.50

2.1

3.7

—

Chronic rhinitis, nasopharyngitis and pharyngitis

340

2602

1.31

5.49

3.1

3.4

—

Alcohol use disorder, ICD-based

496

3979

1.25

5.49

1.9

3.4

—

Nephropathy induced by other drugs, medicaments and biological substances

12.88

5.48

1.6

1.0

—

Faecal incontinence

121

770

1.59

5.48

2.4

3.2

—

Fall involving bed

293

1.99

5.48

2.8

3.6

—

Pediculosis, acariasis and other infestations

138

904

1.54

5.45

2.6

3.6

—

Lichen simplex chronicus

225

2.13

5.45

4.1

4.5

—

Blindness, monocular

3.23

5.44

1.9

4.5

—

Infections with a predominantly sexual mode of transmission

221

1583

1.40

5.44

2.8

3.1

—

Abscess of anal and rectal regions

517

1.72

5.43

2.3

3.5

—

Erythema nodosum

186

2.25

5.43

3.2

4.2

—

Later onset COPD

477

3033

1.26

5.43

2.1

3.4

—

Other noninflammatory disorders of uterus, except cervix

272

1350

1.37

5.42

3.1

3.4

—

Other congenital malformations

399

1.82

5.41

2.0

3.6

—

Conjunctivitis

781

5469

1.20

5.41

3.7

3.3

—

Alzheimer’s disease, strict definition

244

2726

0.73

5.40

2.8

3.0

—

Other and unspecified vascular occlusions

146

973

1.52

5.40

2.9

3.4

—

Menorrhagia

345

1455

1.32

5.37

3.4

3.3

—

Pre-eclampsia or eclampsia

172

1183

1.46

5.36

3.6

3.2

—

Systemic sclerosis, icd10

162

2.34

5.34

2.0

4.1

—

Intracranial and intraspinal abscess and granuloma

2.93

5.34

2.4

5.1

—

COPD, hospital admissions 1, only main diagnosis

523

3620

1.24

5.34

2.0

3.4

—

Alcohol abuse, main dg, excluding more controls

150

1006

1.50

5.33

2.2

3.7

—

Haemorrhagic disorder due to circulating anticoagulants

108

2.69

5.32

2.2

3.8

—

Syndrome of inappropriate secretion of antidiuretic hormone

4.89

5.31

2.3

7.0

—

Abscess of lung

102

2.73

5.31

3.3

5.0

—

Hidradenitis suppurativa

156

2.34

5.28

1.8

3.6

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

137

905

1.52

5.24

3.2

3.6

—

Other diseases of spinal cord

209

2.15

5.22

4.9

4.2

—

Acquired coagulation factor deficiency

11.49

5.22

8.7

1.9

—

Nonorganic sleeping disorders, excluding more controls

164

1124

1.47

5.22

2.4

3.5

—

Cholecystectomy

897

6593

1.18

5.20

3.3

3.4

—

Personality disorders

214

1540

1.40

5.20

2.3

3.3

—

Other disorders of patella

143

956

1.50

5.16

2.3

3.8

—

Type 1 diabetes, definitions combined

318

1.89

5.15

2.7

3.3

—

Adult-onset Still disease

8.82

5.14

1.8

2.5

—

Henoch-Schönlein purpura nephritis (HSPN)

14.04

5.14

1.5

6.5

—

Varicella [chickenpox]

237

2.05

5.12

10.2

3.1

—

Necrotizing fasciitis

5.01

5.12

1.6

2.8

—

Other other unspecified disorders of the circulatory system

279

1.97

5.12

3.7

3.9

—

Hypertension, Pulmonary Arterial

3.69

5.11

1.8

5.8

—

Dermatophytosis

167

1156

1.46

5.10

3.6

3.4

—

Other erythematous conditions

238

2.05

5.10

3.4

4.0

—

Benign neoplasm: salivary glands, exclude unknown (D119)

116

745

1.58

5.09

2.1

3.8

—

Papillary adenocarcinoma of thyroid gland

279

1.96

5.09

3.8

1.4

—

Nail disorders

535

1.68

5.09

2.2

3.6

—

Acute epiglottitis

2.97

5.08

8.6

4.3

—

Varicella [chickenpox]

258

2.00

5.08

9.6

2.9

—

Hyphaema and other vascular disorders of iris and ciliary body

147

2.37

5.08

1.7

4.2

—

Cytomegaloviral pneumonitis

8.92

5.07

3.3

3.5

—

Type 1 diabetes, strict (exclude DM2)

320

1.88

5.06

2.7

3.3

—

Localized skin eruption due to drugs and medicaments

3.06

5.06

2.7

4.4

—

Cerebral palsy and other paralytic syndromes

129

849

1.53

5.05

2.3

3.4

—

Xerosis cutis

123

2.52

5.04

2.9

4.2

—

Pre-eclampsia

157

1075

1.47

5.04

3.8

3.1

—

Rheumatic valve diseases

160

2.30

5.04

4.6

3.6

—

Enthesopathies of lower limb, excluding foot

225

1643

1.38

5.04

2.5

3.2

—

Chronic iridocyclitis

330

1.88

5.02

2.4

3.7

—

Benign neoplasm: Descending colon

106

670

1.61

5.01

2.2

3.6

—

Ingrowing nail

309

1.90

5.00

1.7

3.7

—

Abnormal findings on diagnostic imaging of central nervous system

288

1.94

5.00

2.1

4.2

—

Postprocedural disorders of digestive system, not elsewhere classified

240

2.04

4.99

1.5

4.2

—

Other surgical follow-up care

154

2.31

4.98

2.3

3.7

—

Injury of intra-abdominal organs

148

2.34

4.98

3.5

4.0

—

Pneumonitis due to solids and liquids

122

797

1.55

4.98

2.2

3.2

—

Viral encephalitis, not elsewhere classified/unspecified

130

2.44

4.95

4.3

4.1

—

Migraine without aura and triptan purchases

100

623

1.61

4.94

2.7

3.4

—

Other disorders of peripheral nervous system

4.45

4.93

3.7

4.9

—

Other specified/unspecified bacterial intestinal infections

519

1.68

4.88

4.7

3.5

—

Bullous disorders

489

1.70

4.88

3.2

3.6

—

Carcinoma in situ of skin

132

882

1.52

4.88

4.5

3.4

—

Paraplegia, diplegia of upper limbs

131

2.42

4.86

1.8

4.1

—

Disorders of adult personality and behaviour

220

1610

1.37

4.86

2.3

3.3

—

Pre-eclampsia or poor fetal growth

201

1444

1.39

4.85

3.3

3.1

—

Defects in the complement system

5.42

4.84

5.2

6.6

—

Adhesive capsulitis of shoulder

193

1385

1.40

4.84

2.4

3.7

—

Benign neoplasm of major salivary glands

126

835

1.53

4.82

2.2

3.8

—

Diseases of tongue

460

1.72

4.82

4.2

2.7

—

Chorioretinal inflammation

196

2.13

4.82

3.7

3.9

—

Crohn's disease of small intestine

378

1.79

4.82

1.9

3.7

—

Corticotropin deficiency

3.54

4.81

1.3

4.4

—

Localized swelling, mass and lump of skin and subcutaneous tissue

370

2918

1.27

4.81

3.6

3.2

—

Progressive systemic sclerosis

5.00

4.81

1.8

7.4

—

Acute pharyngitis

105

661

1.58

4.80

4.4

3.3

—

Epilepsy

351

2742

1.28

4.80

2.4

3.5

—

Other female pelvic inflammatory diseases

166

1162

1.44

4.79

2.6

3.5

—

Tularaemia

2.87

4.78

4.5

4.3

—

Synovial cyst of popliteal space [Baker]

576

1.63

4.77

4.2

3.6

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

3.46

4.77

3.5

5.4

—

Postprocedural musculoskeletal disorders, not elsewhere classified

101

639

1.60

4.77

3.5

3.7

—

Primary open-angle glaucoma

479

3765

1.24

4.77

3.6

3.3

—

Carcinoma in situ of skin of trunk

316

1.88

4.75

4.5

3.7

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

6.68

4.74

1.5

5.2

—

Transport accidents

451

3127

1.24

4.74

2.7

3.5

—

Systemic disorders of connective tissue in diseases classified elsewhere

7.58

4.74

11.4

3.9

—

Retinal detachments and breaks

483

3935

1.23

4.73

3.5

—

Irregular menses

356

2202

1.28

4.72

3.7

3.3

—

Glaucoma secondary to other eye disorders

338

1.84

4.70

2.6

3.8

—

Benign neoplasm: Kidney

281

1.92

4.69

1.8

4.0

—

Injuries to the neck

222

1638

1.36

4.69

3.4

3.3

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

130

871

1.50

4.68

3.6

3.4

—

Somnolence

3.18

4.68

2.2

3.6

—

Complications of other internal prosthetic devices, implants and grafts

324

1.85

4.68

2.5

3.4

—

Papilloedema, unspecified

121

2.44

4.68

1.4

4.2

—

Cramp and spasm

295

1.89

4.68

3.6

3.8

—

Strabismus

265

2003

1.33

4.68

3.0

3.3

—

Benign neoplasm of other and unspecified intrathoracic organs

3.00

4.67

2.8

5.4

—

Cervicobrachial syndrome

221

1631

1.36

4.66

3.6

3.3

—

Left bundle-branch block

503

1.67

4.64

2.3

3.2

—

Aspergillosis

3.10

4.64

2.1

4.7

—

Perforation of tympanic membrane

115

754

1.54

4.63

3.4

3.5

—

Event of undetermined intent

354

1.80

4.61

3.4

—

Amenorrhoea

199

2.07

4.59

1.7

3.4

—

Portal vein thrombosis

129

2.40

4.58

2.7

4.0

—

Other and unspecified urticaria

185

1331

1.40

4.58

4.2

3.2

—

Other aneurysm

506

1.67

4.58

2.6

3.5

—

Vascular dementia (other)

3.30

4.57

1.0

4.5

—

Fracture of skull and facial bones

230

1714

1.35

4.57

3.8

3.3

—

Conductive hearing loss, unspecified

606

1.60

4.57

4.1

3.5

—

Scabies

248

1.96

4.56

4.6

3.2

—

Pneumonia due to Haemophilus influenzae

7.10

4.56

10.4

1.2

—

Benign neoplasm: Parotid gland

104

670

1.57

4.55

2.0

3.7

—

Erosion of teeth , including avohilmo

214

1578

1.36

4.54

2.9

3.4

—

Chronic laryngitis and laryngotracheitis

169

1201

1.42

4.52

2.4

3.2

—

severe traumatic brain injury, does not include concussion

309

2405

1.29

4.52

3.3

3.1

—

Entropion and trichiasis of eyelid

136

930

1.48

4.51

3.4

3.3

—

Convalescence

299

1.86

4.49

4.6

3.3

—

Ethmoidectomy

134

913

1.48

4.49

3.0

3.8

—

Alzheimer’s disease (Late onset)

230

2567

0.75

4.48

2.9

—

Other benign neoplasms of skin

474

3878

1.23

4.48

4.4

3.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

105

2.50

4.47

4.8

4.0

—

Autoimmune hepatitis

4.20

4.46

1.4

5.3

—

FESS (DNB20)

129

874

1.49

4.45

2.9

3.8

—

L01XE Protein kinase inhibitors

495

1.66

4.44

1.8

4.0

—

Other extrapyramidal and movement disorders in other diseases

299

2323

1.30

4.44

2.3

3.4

—

Rapidly progressive nephritic syndrome

6.89

4.43

1.3

5.9

—

Macular pucker

230

1726

1.35

4.43

2.8

3.7

—

Corneal ulcer

188

1365

1.39

4.42

2.9

3.3

—

Erythema multiforme

150

2.25

4.42

3.6

4.1

—

Idiopathic hypercalciuria

4.47

4.41

2.3

6.2

—

Injury of unspecified body region

596

1.59

4.41

1.4

3.5

—

Other and unspecified erythematous conditions

217

2.02

4.40

3.7

3.9

—

Chronic conjunctivitis

183

2.11

4.40

2.7

4.3

—

Paralytic strabismus

605

1.59

4.39

2.9

3.6

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

5.86

4.38

1.7

4.9

—

Specific personality disorders

180

1299

1.39

4.38

2.0

3.5

—

Other and unspecified diseases of spleen

5.83

4.38

3.1

6.3

—

Polyglandular dysfunction

9.62

4.37

1.4

10.1

—

Amputation of thigh

274

1.90

4.37

1.9

3.6

—

Disorders of synovium and tendon in diseases classified elsewhere

138

2.30

4.36

1.4

3.5

—

Other mycoses, not elsewhere classified/unspecified

107

2.49

4.35

3.1

4.6

—

Panniculitis, unspecified

2.87

4.35

2.1

4.3

—

Lung transplant status

3.17

4.32

3.0

3.4

—

Lung transplantation

3.17

4.32

3.0

3.4

—

Hyperfunction of pituitary gland

218

1.99

4.32

4.8

3.8

—

Glaucoma suspect

488

4022

1.22

4.31

3.3

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

126

2.35

4.31

3.1

1.3

—

Acquired absence of organs, not elsewhere classified

2.77

4.31

5.5

4.5

—

Other symptoms and signs involving general sensations and perceptions

282

1.87

4.31

1.8

3.8

—

Bursitis of shoulder

165

2.16

4.29

4.3

4.2

—

Malignant neoplasm of oral cavity, including Hilmo

297

1.84

4.28

2.5

1.4

—

Assault by bodily force

341

1.77

4.24

2.1

3.5

—

Fitting and adjustment of external prosthetic device

6.34

4.23

4.7

3.8

—

Encephalopathy

3.00

4.23

5.3

5.1

—

Malignant neoplasm of mesothelium and soft tissue

277

1.87

4.22

6.2

1.4

—

3.17

4.22

1.8

5.0

—

Operations for atrial fibrillation

128

2.34

4.21

1.2

4.6

—

Use of donepezil

193

2484

0.74

4.20

2.3

3.0

—

Brain meningioma, including Hilmo

343

1.77

4.20

3.6

1.4

—

Panic disorder

642

1.55

4.19

2.4

3.7

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

293

2276

1.29

4.18

3.1

3.2

—

Abnormal blood-pressure reading, without diagnosis

256

1.90

4.18

4.5

3.3

—

Open wound of thorax

2.59

4.18

3.1

4.4

—

Juvenile rheumatoid arthirtis

2.70

4.18

1.4

4.1

—

Bronchitis, not specified as acute or chronic

636

1.55

4.17

2.6

3.7

—

Oligomenorrhoea

134

2.26

4.17

2.9

4.1

—

Sequelae of malnutrition and other nutritional deficiencies

8.72

4.16

3.9

1.7

—

Delivery

286

1938

0.78

4.14

4.1

3.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

246

1881

1.31

4.14

3.5

3.4

—

Type1 diabetes, definitions combined, early onset

140

2.22

4.14

1.5

2.0

—

Excessive attrition of teeth

555

4647

1.20

4.14

3.3

3.4

—

Metabolic disorder, other/unspecified

8.50

4.13

4.1

8.0

—

Other hereditary haemolytic anaemias

4.81

4.12

1.3

3.7

—

Other enthesopathies

301

2364

1.28

4.11

3.4

3.7

—

Sphingolipidosis, other/unspecified

10.91

4.10

7.0

1.0

—

Impetigo

195

2.02

4.09

3.1

4.0

—

Haemolytic-uraemic syndrome

10.72

4.08

1.9

5.3

—

Common variable immunodeficiency

4.38

4.08

1.6

3.8

—

Adrenogenital disorders

5.28

4.08

5.7

8.7

—

Residual foreign body in soft tissue

302

1.81

4.06

4.0

—

Sacroiliitis, not elsewhere classified

175

2.08

4.06

1.5

3.1

—

Other salmonella infections

238

1.92

4.04

3.6

3.5

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

125

859

1.46

4.03

3.0

3.1

—

Pleural plaque

152

1086

1.42

4.03

2.8

3.6

—

Hepatocellular carcinoma

163

2.13

4.03

2.2

1.4

—

Brachial plexus disorders

484

1.62

4.01

3.5

3.6

—

Follicular adenocarcinoma of thyroid gland, including Hilmo

3.11

4.01

2.8

1.3

—

Eating disorders

354

1.73

4.00

2.4

3.1

—

Mixed and other personality disorders

385

1.70

4.00

3.0

3.4

—

Other and unspecified follicular disorders

246

1.90

4.00

2.1

3.6

—

Brain meningioma

326

1.77

4.00

3.4

1.4

—

Ulcerative ileocolitis

218

1.95

3.98

2.6

3.7

—

Anuria and oliguria

3.39

3.97

1.2

4.8

—

Other factor of the environment

2.79

3.97

3.5

3.9

—

Atlantoaxial subluxation

3.95

3.96

1.2

4.7

—

Necrosis of pulp, including avohilmo

572

4809

1.19

3.96

4.2

3.3

—

Selective deficiency of immunoglobulin G [IgG] subclasses

4.22

3.96

2.0

5.2

—

Migraine with aura

178

1306

1.37

3.95

2.9

3.6

—

Thyroiditis

456

1.64

3.94

2.8

3.7

—

Status epilepticus

262

1.86

3.93

1.4

4.3

—

Malignant neoplasm of digestive organs

452

2940

1.22

3.92

2.3

1.5

—

Malignant neoplasm of liver and intrahepatic bile ducts

206

1.98

3.91

1.8

1.4

—

Open wound of abdomen, lower back and pelvis

165

2.09

3.89

2.6

3.8

—

Dislocation of lens

107

2.39

3.88

3.0

4.0

—

Selective deficiency of immunoglobulin A [IgA]y

6.28

3.87

2.8

11.6

—

Obsessive-compulsive disorder

192

1.99

3.87

2.0

3.4

—

Recurrent or chronic depression

360

2035

1.25

3.86

3.1

3.6

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

9.47

3.86

15.9

5.1

—

Tularaemia

120

2.30

3.85

5.1

4.3

—

Other conditions related to polyarteritis nodosa

9.36

3.84

2.3

3.3

—

Kidney diseases associated to Fabry's disease

13.00

3.84

8.0

1.0

—

Renal cell carcinoma of kidney

250

1.87

3.84

1.8

1.4

—

Monocytic leukaemia

4.47

3.82

2.8

3.5

—

Other specified congenital malformation syndromes affecting multiple systems

3.11

3.82

1.3

4.0

—

Shock, not elsewhere classified

3.27

3.81

5.5

3.4

—

Disorders of optic nerve and visual pathways

626

1.53

3.81

3.7

3.5

—

Other and unspecified injuries of shoulder and upper arm

201

1.97

3.80

2.9

4.0

—

Malignant neoplasm of tongue, including Hilmo

160

2.10

3.80

3.3

1.3

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

313

2497

1.26

3.80

3.5

3.3

—

Testicular dysfunction

215

1.93

3.80

3.8

3.3

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

2.74

3.80

1.4

4.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

211

1.92

3.79

4.0

3.1

—

Congenital malformations of gallbladder, bile ducts and liver

3.00

3.79

2.1

4.9

—

Diseases of middle ear and mastoid

528

3624

1.19

3.78

4.2

3.1

—

Morphin

134

2.21

3.77

2.4

2.3

—

Nonspecific lymphadenitis

347

1.72

3.76

2.6

3.7

—

Other primary thrombocytopenia

5.28

3.76

3.2

5.0

—

Benign neoplasm: Pancreas

238

1.89

3.75

2.7

4.5

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

2.55

3.75

2.6

1.2

—

Liver disorders in diseases classified elsewhere

7.10

3.74

1.1

3.9

—

Heartburn

114

783

1.47

3.74

3.3

—

Sequelae of tuberculosis

135

2.19

3.71

3.5

3.7

—

Otalgia

495

1.59

3.70

3.2

3.4

—

Lifestyle-related condition

2.76

3.70

3.1

3.3

—

Melanoma in situ of other and unspecified parts of face

110

2.35

3.69

3.7

4.8

—

Malignant neoplasm of colon, including Hilmo

224

1720

1.31

3.69

2.8

1.5

—

Disorders of tooth development and eruption

134

765

1.42

3.69

3.2

2.7

—

Hyperkinetic disorders, excluding more controls

180

1.97

3.68

1.4

3.1

—

Mouth breathing

445

3693

1.21

3.67

3.3

3.4

—

Thyrotoxicosis with toxic multinodular goitre

497

1.59

3.67

1.6

3.5

—

Single spontaneous delivery

290

1937

0.79

3.67

4.0

3.1

—

Third [oculomotor] nerve palsy

136

2.18

3.66

1.4

4.5

—

Early onset COPD

281

2226

1.27

3.66

1.9

3.5

—

UC patients in KELA-register (code 208), prior to 1994

328

1.73

3.66

3.0

3.7

—

Fall on same level involving ice and snow

661

5683

1.17

3.65

2.9

3.4

—

Certain zoonotic bacterial diseases

123

2.24

3.65

3.9

—

Mental and behavioural disorders due to tobacco

617

1.52

3.64

2.2

4.0

—

Astigmatism

335

1.71

3.63

2.8

4.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

351

1.69

3.62

2.9

3.5

—

Benign neoplasm: Bladder

2.74

3.61

1.9

4.8

—

Congenital deformities of feet

163

2.05

3.61

2.1

3.5

—

Absence of one kidney

8.19

3.61

1.6

9.9

—

Hypothyroidism due to medicaments and other exogenous substances

2.64

3.60

1.9

4.6

—

Malignant neoplasm of other and unspecified parts of tongue

2.56

3.59

2.4

1.2

—

Otitis externa

229

1773

1.30

3.57

3.8

3.3

—

Other disorders of optic [2nd] nerve and visual pathways

445

1.61

3.57

3.7

3.9

—

Congenital malformations of trachea and bronchus

2.90

3.57

1.6

6.2

—

Felty syndrome

3.79

3.57

1.8

6.4

—

Schizophrenia or delusion, excluding more controls

270

2112

1.27

3.56

2.7

3.4

—

Manic episode

171

2.02

3.56

3.0

4.5

—

Disorders of sphingolipid metabolism and other lipid storage disorders

6.47

3.56

6.3

1.9

—

Calculus of kidney and ureter

383

3150

1.22

3.55

2.9

3.4

—

Atypical mycobacterium lung infection

2.44

3.54

2.0

3.7

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

576

4771

1.18

3.53

3.3

3.4

—

Ulcerative colitis (strict) with PSC

3.99

3.53

1.2

5.2

—

Chondropathies

141

1018

1.39

3.53

3.8

3.3

—

Other and unspecified rosacea

646

1.50

3.52

3.0

3.7

—

Smoking dependency

622

1.51

3.51

2.2

4.0

—

Malignant neoplasm of renal pelvis, including Hilmo

2.60

3.51

4.5

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

430

1.58

3.50

2.7

2.5

—

Umbilical hernia

312

2516

1.25

3.49

3.0

3.5

—

Atopic dermatitis, strict definition

191

1417

1.32

3.47

2.5

3.2

—

Necrobiosis lipoidica, not elsewhere classified

4.71

3.47

3.7

5.7

—

Pediculosis, acariasis and other infestations

348

1.68

3.47

4.0

3.4

—

Benign neoplasm of mouth and pharynx

128

913

1.41

3.46

3.9

3.5

—

Pneumothorax

560

1.53

3.46

2.9

3.5

—

Eating disorder

200

1.90

3.46

2.4

3.0

—

Other disorders of pigmentation

326

1.71

3.46

3.7

—

Use of rivastigmine

133

1824

0.72

3.45

2.3

3.0

—

Disorders of refraction and accommodation

225

1739

1.29

3.45

2.9

3.2

—

Antenatal screening

520

0.60

3.45

3.3

3.1

—

Colitis, primary sclerosing

2.81

3.45

1.2

4.1

—

Benign neoplasm: Liver/bile ducts

146

2.09

3.44

4.6

4.3

—

Hypertrophy of (infrapatellar) fat pad

3.05

3.44

3.7

5.8

—

Benign neoplasm: Heart

5.31

3.44

1.4

7.9

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

505

1.56

3.44

2.6

1.5

—

Benign neoplasm: Parathyroid gland

2.52

3.44

2.0

5.6

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

132

751

1.41

3.43

2.4

3.6

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

5.23

3.42

1.0

5.1

—

Carcinoma in situ of other and unspecified digestive organs

305

1.74

3.42

4.2

4.1

—

Suggestive for eosinophilic asthma

107

741

1.46

3.41

2.0

3.8

—

Anorexia

2.55

3.41

2.1

4.4

—

Other salmonella infections

260

1.79

3.40

3.5

3.6

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

109

758

1.45

3.40

4.3

3.7

—

Colitis, primary sclerosing, strict definition

3.16

3.40

1.2

4.7

—

Carcinoma in situ of skin of upper limb, including shoulder

254

1.81

3.40

3.6

3.7

—

Follow-up examination after treatment for malignant neoplasms

127

908

1.41

3.40

2.5

2.9

—

Osteomyelitis of vertebra

4.65

3.39

4.2

3.3

—

Ovarian dysfunction

188

1.92

3.38

3.5

3.4

—

Disorders of orbit

291

1.74

3.36

4.0

3.7

—

Drug-induced autoimmune haemolytic anaemia

9.54

3.36

6.3

1.7

—

Acute myringitis

4.47

3.34

14.8

7.7

—

therapeutic use

255

1.80

3.33

1.7

4.2

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

9.21

3.33

6.3

1.0

—

Perichondritis of external ear

135

2.12

3.32

6.8

3.7

—

Agoraphobia

2.38

3.32

2.3

3.1

—

Other congenital malformations

662

1.47

3.31

2.0

3.7

—

Alcohol abuse, main dg

150

1107

1.36

3.31

2.2

3.6

—

Myocardial infarction, with ST-elevation

249

1972

1.27

3.30

1.9

3.2

—

Overexertion and strenuous or repetitive movements

672

1.47

3.29

4.8

3.7

—

Acute otitis externa, noninfective

109

2.25

3.29

3.0

4.1

—

Sequelae of injuries of upper limb

681

1.46

3.28

3.4

3.8

—

Allergic contact dermatitis

116

822

1.42

3.26

2.4

3.7

—

Labour and delivery complicated by fetal stress [distress]

455

0.56

3.26

1.7

2.8

—

Lipomatosis, not elsewhere classified

5.68

3.26

1.1

5.1

—

IBD (strict) with PSC

3.42

3.25

1.2

4.6

—

Other and unspecified mood [affective] disorders

271

1.74

3.25

2.0

3.5

—

Infections with a predominantly sexual mode of transmission

257

1903

1.26

3.23

2.7

3.1

—

Acute inflammation of orbit

4.29

3.23

5.3

2.4

—

Other disorders of eye and adnexa

133

967

1.38

3.23

2.5

3.5

—

Drug-induced systemic lupus erythematosus

3.92

3.23

1.4

3.5

—

Injury of nerves at lower leg level

2.93

3.22

2.0

4.5

—

Testicular hypofunction

185

1.92

3.22

4.2

3.5

—

Superficial injury of shoulder and upper arm

118

842

1.41

3.21

2.2

3.4

—

Thiamine deficiency

3.40

3.20

4.1

5.4

—

Universal erythroderma, KELA reimbursement

104

2.27

3.20

1.9

4.3

—

Other problems related to primary support group, including family circumstances

422

1.57

3.18

2.6

3.7

—

Intermittent heterotropia

221

1.82

3.18

2.9

3.9

—

Other noninfective disorders of lymphatic vessels and lymph nodes

244

1.79

3.17

1.6

4.0

—

Temporomandibular joint disorders, including avohilmo

348

2827

1.22

3.17

4.1

3.4

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

588

1.49

3.17

4.5

3.7

—

Campylobacter enteritis

165

1.97

3.17

3.2

4.2

—

Chronic diseases of tonsils and adenoids

613

4482

0.86

3.17

3.2

3.5

—

Ulcerative rectosigmoiditis

515

1.53

3.16

3.8

—

Toxic liver disease

2.29

3.16

1.6

4.1

—

Other contact dermatitis

507

1.53

3.16

2.1

3.8

—

Rheumatic fever incl heart disease

237

1.80

3.16

6.6

3.7

—

Disturbances of smell and taste

297

1.70

3.15

3.7

4.4

—

Emotionally unstable personality disorder

475

1.54

3.15

1.9

3.5

—

Other and unspecified trigeminal disorders

2.33

3.13

4.6

4.1

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

275

1.73

3.13

3.2

4.0

—

Other meningitis

2.33

3.13

2.1

4.3

—

Erythema intertrigo

159

1.98

3.13

2.6

5.0

—

Urolithiasis

413

3468

1.20

3.12

2.9

3.3

—

Myopia

614

1.47

3.11

2.6

3.5

—

Scleritis and episcleritis

367

1.62

3.11

2.8

3.6

—

Sixth [abducent] nerve palsy

261

1.75

3.10

4.6

4.1

—

Pustulosis palmaris et plantaris

291

1.70

3.09

2.5

4.0

—

Colonic or urogenital fistula

302

2463

1.23

3.09

3.4

3.3

—

Malignant neoplasm of breast

373

2014

1.21

3.09

3.3

1.5

—

Malignant neoplasm of small intestine

139

2.05

3.09

3.7

1.4

—

Cystic disease of liver

3.00

3.07

2.2

5.3

—

Polyglandular dysfunction, other/unspecified

11.30

3.07

1.6

16.8

—

Malignant neoplasm of eye and adnexa, including Hilmo

2.30

3.06

5.8

1.3

—

Leiomyoma of uterus

613

2998

1.16

3.06

3.4

3.3

—

Raynaud syndrome

552

1.50

3.05

2.0

3.6

—

Benign neoplasm: Liver

126

2.10

3.05

5.2

4.6

—

Excessive earwax

693

5921

1.15

3.05

3.6

3.3

—

Bulimia nervosa (incl. atypical)

2.60

3.05

1.6

3.2

—

Acne conglobata

5.99

3.04

6.7

1.4

—

Other disorders starting during childhood or adolecense, excluding more controls

2.80

3.04

4.9

3.3

—

Enteritis due to Yersinia enterocolitica

4.44

3.03

4.2

4.8

—

Other specified and unspecified personality disorders

456

1.54

3.03

2.7

3.6

—

conjunctival haemorrhage

694

1.44

3.02

3.0

3.4

—

Osteosarcoma

10.52

3.01

1.2

1.0

—

Bell's palsy

125

912

1.38

3.01

3.6

3.5

—

Viral meningitis

161

1.95

3.01

1.5

3.8

—

Nonorganic sleeping disorders

164

1246

1.32

3.00

2.4

3.4

—

Achalasia of cardia

134

2.06

3.00

4.9

—

Sequelae of injuries of neck and trunk

190

1.87

2.99

4.5

4.0

—

Other acantholytic disorders

5.03

2.99

1.4

3.8

—

Embolic stroke with flimmer

205

1.83

2.97

3.2

—

Malignant neoplasm of breast, including Hilmo

377

2031

1.20

2.97

3.3

1.5

—

Congenital malformations and deformations of the musculoskeletal system

346

1.62

2.96

2.2

3.4

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

4.88

2.95

2.5

1.2

—

Hyposplenism

7.33

2.95

6.3

13.7

—

Other and unspecified disorders of binocular movement

4.85

2.95

5.8

7.1

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

156

1.96

2.94

2.9

4.1

—

Other specified/unspecified dorsopathies

213

1.81

2.94

4.2

3.5

—

Cluster headache, wide

191

1.85

2.94

1.3

4.7

—

Fibroblastic disorders

279

2271

1.23

2.93

2.8

3.5

—

Other leukaemias of specified cell type

5.73

2.93

9.1

5.5

—

Contraceptive management

215

1904

0.79

2.92

3.8

3.3

—

Disorders of brain, other and unspecified

2.76

2.92

1.2

4.4

—

ILD medications: pirfenidone

2.57

2.91

2.6

2.0

—

Absence of one kidney

7.02

2.91

1.7

9.9

—

Hereditary hypogammaglobulinemia

5.62

2.91

1.1

7.7

—

Arthropathy in neoplastic disease

10.40

2.91

21.6

7.3

—

Benign neoplasm: Skin of other and unspecified parts of face

130

961

1.36

2.90

3.2

3.3

—

Cushing syndrome

2.56

2.90

1.3

5.0

—

Periapical abscess

481

4119

1.17

2.90

3.2

3.5

—

Excessive vomiting in pregnancy

319

1.64

2.90

2.7

4.0

—

Dermatographic urticaria

366

1.60

2.90

4.6

3.8

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

376

2031

1.20

2.90

3.3

1.5

—

Malignant neoplasm of small intestine, including Hilmo

207

1.81

2.89

4.5

1.4

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.62

2.89

8.9

4.5

—

Vasomotor and allergic rhinitis

315

2550

1.22

2.89

3.1

3.3

—

Type 1 diabetes, strict definition

177

1.87

2.88

1.5

2.7

—

Other acute skin changes due to ultraviolet radiation

252

1.73

2.87

2.5

3.7

—

Heterophoria

422

1.55

2.87

3.2

3.7

—

Other disorders of conjunctiva

178

1380

1.30

2.86

3.0

3.5

—

Follicular adenocarcinoma of thyroid gland

3.45

2.85

3.2

1.4

—

Other and specified injuries of hip and thigh

165

1.91

2.84

1.8

4.1

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.73

2.83

3.9

3.7

—

Allergic purpura

172

1.88

2.83

1.7

4.1

—

Migraine with aura and triptan purchases

635

1.44

2.83

2.5

3.4

—

Type 1 diabetes, strict definition, subgroup 1

157

1.91

2.82

1.5

2.7

—

Chronic myeloid leukaemia

4.08

2.82

1.8

1.2

—

Vulvovaginal ulceration/inflammation in other diseases

223

1.76

2.82

4.4

3.9

—

Use of antiglaucoma preparations and miotics

113

822

1.39

2.81

2.9

3.1

—

Supervision of normal pregnancy

501

0.64

2.81

3.3

3.2

—

Hand

4.04

2.81

2.8

2.4

—

Diffuse (eosinophilic) fasciitis

9.03

2.81

2.0

12.7

—

Carcinoma in situ of skin of lower limb, including hip

195

1.83

2.81

5.0

4.1

—

Familial chondrocalcinosis

6.82

2.80

2.0

2.2

—

Malignant melanoma, including Hilmo

190

1489

1.28

2.80

4.8

1.5

—

Disorders of optic nerve, not elsewhere classified

166

1.90

2.80

4.7

4.0

—

Obstructed labour due to malposition and malpresentation of fetus

810

0.64

2.80

3.2

—

Benign neoplasm: Tongue

217

1.78

2.79

3.0

4.2

—

Chylothorax

5.37

2.79

1.4

2.1

—

Other congenital malformations of skin

224

1.76

2.79

1.6

4.2

—

Gluteal tendinitis

239

1.73

2.79

1.8

4.1

—

Malignant neoplasm of breast, HER2-negative

367

2007

1.20

2.79

3.3

1.5

—

Exclusion endpoint for clefts

2.57

2.79

1.3

3.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

179

1375

1.29

2.78

3.2

—

Other specific arthropathies, wide

124

2.05

2.78

2.8

5.0

—

Tuberculosis of other organs, strict

188

1.84

2.78

1.8

3.9

—

Redundant prepuce, phimosis and paraphimosis

205

1607

1.27

2.77

2.9

3.4

—

Malignant neoplasm of thymus

5.23

2.77

1.3

1.0

—

Other and unspecified abdominal hernia

340

1.61

2.76

1.5

3.6

—

Malignant neoplasm of adrenal gland

5.19

2.76

2.7

1.0

—

Spontaneous abortion

257

2130

0.81

2.75

3.0

3.5

—

Carcinoma in situ of oral cavity

6.36

2.74

12.5

2.1

—

Ulcerative enterocolitis

174

1.86

2.74

2.0

4.2

—

Postviral fatigue syndrome

5.08

2.74

2.3

4.3

—

Other injuries of upper limb, level unspecified

2.48

2.74

4.0

3.9

—

Certain zoonotic bacterial diseases

211

1.78

2.73

4.5

3.7

—

LSIL lesion of the vagina

2.47

2.73

3.6

4.5

—

Senility

2.75

2.72

2.0

3.1

—

Cerebral cysts

333

1.60

2.72

3.2

3.6

—

Guillain-Barre syndrome

105

2.14

2.72

3.0

4.5

—

Other specified and unspecified disorders of iris and ciliary body

4.39

2.72

1.9

7.9

—

Other disorders of penis

105

759

1.39

2.71

2.0

3.6

—

Focal epilepsy

226

1815

1.25

2.71

2.7

3.4

—

Acne

263

1.68

2.70

3.4

2.5

—

Inflammatory disorders of male genital organs, not elsewhere classified

2.22

2.70

1.5

4.2

—

Other keratitis

102

734

1.40

2.70

1.8

3.5

—

Other diseases of gallbladder

358

1.58

2.69

3.9

3.4

—

Other menopausal disorders

179

1290

0.78

2.69

3.4

3.5

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

366

1.57

2.69

2.8

1.4

—

Complications of genitourinary prosthetic devices, implants and grafts

161

1.89

2.69

2.1

3.2

—

Disorders of purine and pyrimidine metabolism

3.26

2.69

3.6

—

Benign neoplasm: Skin of eyelid, including canthus

188

1481

1.28

2.69

4.6

3.4

—

Congenital deformities of feet

2.20

2.68

2.2

4.0

—

Malignant neoplasm of oropharynx, including Hilmo

133

1.99

2.68

5.7

1.2

—

Disorders of plasma-protein metabolism, not elsewhere classified

3.24

2.68

1.5

4.3

—

Crystalline deposits in vitreous body

2.46

2.67

3.8

4.3

—

Other misadventures during surgical and medical care

176

1.85

2.67

2.3

4.7

—

Benign paroxysmal vertigo

358

3017

1.19

2.67

3.5

3.3

—

Melanocytic naevi

288

2378

1.22

2.66

3.5

3.3

—

Congenital malformations of the respiratory system

2.15

2.66

2.0

4.9

—

Biomechanical lesions, not elsewhere classified

367

1.57

2.66

2.1

3.8

—

Intercostal neuropathy

2.73

2.66

5.2

4.5

—

Malignant neoplasm of tonsil, including Hilmo

106

2.11

2.66

5.8

1.3

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

2.35

2.66

1.2

2.0

—

Benign neoplasm: Cerebral meninges

110

805

1.38

2.66

3.7

3.5

—

Congenital iodine-deficiency syndrome/hypothyroidism

213

1.76

2.66

5.1

3.4

—

Supervision of high-risk pregnancy

505

0.64

2.65

2.4

3.1

—

Benign neoplasm of meninges

120

891

1.36

2.64

3.5

3.4

—

Stenosis and insufficiency of lacrimal passages

109

797

1.38

2.64

2.6

3.2

—

Failure of sterile precautions during surgical operation

4.92

2.64

1.3

3.8

—

Striae atrophicae

2.98

2.64

1.4

6.5

—

Cluster headache, strict

169

1.85

2.64

1.4

4.7

—

Other and unspecified localized connective tissue disorders

4.89

2.64

7.3

11.1

—

Chronic Coagulation defects

113

2.06

2.63

4.3

4.6

—

Autoimmune thyroiditis

2.18

2.63

3.9

4.3

—

Colitis due to radiation

2.36

2.62

5.4

4.6

—

CR(E)ST syndrome

100

2.14

2.62

2.1

3.8

—

Peritonsillar abscess

169

1317

1.29

2.62

3.4

3.3

—

Tongue abnormality

498

1.48

2.61

4.5

3.5

—

Other strabismus

181

1418

1.28

2.61

3.0

3.3

—

Non-small cell lung cancer, including Hilmo

179

1324

1.28

2.61

2.3

1.5

—

Injury of nerves at forearm level

2.34

2.60

2.3

3.5

—

Transient acantholytic dermatosis [Grover]

5.87

2.60

1.2

4.8

—

Kwashiorkor

7.69

2.60

2.6

5.3

—

Extrapyramidal and movement disorders

484

4190

1.16

2.59

2.3

3.4

—

Dislocation, sprain and strain of joints and ligaments of head

192

1.79

2.59

3.5

3.3

—

Nystagmus and other irregular eye movements

2.39

2.58

4.1

4.9

—

Orthopaedic devices associated with adverse incidents

164

1.87

2.58

1.8

4.4

—

Unspecified event, undetermined intent

135

1.95

2.57

3.2

4.2

—

Ulcer of vagina/vulva

135

1.95

2.57

2.3

4.5

—

Retrobulbar neuritis in diseases classified elsewhere

5.64

2.57

6.5

2.1

—

Other and unspecified nonorganic psychotic disorders

140

1067

1.32

2.57

2.5

3.6

—

Other specified disorders of muscle

193

1.78

2.56

2.5

3.9

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

2.66

2.56

6.2

1.1

—

Crohn disease (strict definition, require KELA, min 2 HDR)

315

1.60

2.55

1.8

3.5

—

Malignant neoplasm of bladder

591

1.43

2.55

2.6

1.5

—

Lesion of radial nerve

246

1.69

2.55

3.4

3.7

—

Malignant neoplasm of anus and anal canal, including Hilmo

2.32

2.54

1.6

1.3

—

Hypermobility syndrome

164

1.84

2.53

3.9

4.0

—

Urethritis and urethral syndrome

136

1.94

2.52

2.7

4.5

—

Mononeuritis multiplex

4.61

2.52

1.7

3.9

—

Fenamates

172

911

1.29

2.52

2.8

3.2

—

Blindness or visual impairment, binocular

3.59

2.52

2.9

4.5

—

Glaucoma secondary to drugs

4.58

2.51

4.3

2.3

—

Psychotic depression

364

1.55

2.51

3.4

4.1

—

Episcleritis

309

1.60

2.51

2.8

3.8

—

Other and unspecified acute skin changes due to ultraviolet radiation

195

1.77

2.49

2.6

3.8

—

Fatigue fracture of vertebra

3.94

2.49

3.9

4.4

—

Pregnancy hypertension

285

2118

1.21

2.49

3.2

3.3

—

Other/unspecified enthesopathies of lower limb, excluding foot

405

1.52

2.49

2.0

3.5

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.99

2.48

1.2

2.6

—

Speech and linguistic disorders, excluding more controls

232

1.67

2.48

2.2

3.7

—

Tic and related disorders

4.42

2.48

8.4

5.6

—

Pseudomembranous colitis

2.73

2.48

2.5

4.8

—

Carcinoma in situ of colon

181

1.81

2.48

5.9

4.5

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.12

2.47

1.3

3.0

—

Maternal care for known or suspected malpresentation of fetus

390

0.57

2.47

4.8

3.1

—

Lagophthalmos

2.13

2.46

4.9

4.1

—

Malignant neoplasm of nasal cavity and sinuses

3.22

2.46

7.6

1.2

—

Infective bursitis

226

1.71

2.46

4.9

4.2

—

Metatarsalgia

646

1.40

2.46

2.9

3.7

—

Hyperchylomicronaemia

5.34

2.45

1.2

1.4

—

Malignant neoplasm of oral cavity

226

1.70

2.45

2.2

1.4

—

Carcinoma in situ of lip

7.00

2.45

10.4

2.5

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

197

1579

1.25

2.45

2.9

3.5

—

Generalized anxiety disorder

671

1.39

2.45

2.2

3.7

—

Benign neoplasm: Vertebral column

5.26

2.44

2.3

2.8

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

2.97

2.44

3.9

1.4

—

Tuberculosis of other organs

167

1.83

2.44

1.8

4.1

—

Hereditary deficiency of other clotting factors

2.96

2.43

7.1

5.9

—

Granulomatous disorders of skin and subcutaneous tissue

145

1.89

2.43

3.0

4.1

—

Perioral dermatitis

103

2.07

2.43

1.6

4.1

—

Anti-inflammatory and antirheumatic products, non-steroids

335

1411

1.20

2.43

3.7

3.1

—

Inflammation of lacrimal passages (acute and unspecified)

117

2.00

2.43

3.3

3.8

—

Nontoxic multinodular goitre

230

1878

1.23

2.43

3.6

3.4

—

Pustular psoriasis

312

1.59

2.42

2.5

4.0

—

Delivery, wide proxy

250

1616

0.82

2.42

3.7

2.9

—

Other secondary coxarthrosis

250

1.66

2.42

1.5

3.8

—

Malignant neoplasm of adrenal gland, including Hilmo

3.41

2.41

2.4

1.1

—

Localized scleroderma [morphea]

2.15

2.41

2.1

4.6

—

Disorders of porphyrin and bilirubin metabolism

2.39

2.41

4.1

4.7

—

Other haemoglobinopathies

6.62

2.41

1.2

4.8

—

Congenital malformations of the respiratory system

2.14

2.40

2.1

5.2

—

Benign neoplasm: Prostate

2.59

2.40

3.0

3.8

—

Childhood asthma (age<16), excluding more controls

159

1.74

2.39

3.2

1.6

—

Impaction of intestines

2.69

2.39

4.0

2.9

—

Chromophobe cell carcinoma of kidney

3.75

2.39

2.5

1.0

—

Sequelae of infectious and parasitic diseases

524

1.44

2.39

3.5

3.2

—

Personal history of allergy to drugs, medicaments and biological substances

2.46

2.39

1.1

4.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.45

2.39

4.4

4.8

—

Injury of nerves and spinal cord at neck level

161

1.83

2.38

3.5

4.5

—

Abscess of tendon sheath

2.91

2.37

1.1

3.7

—

Open wound of shoulder and upper arm

118

1.98

2.37

1.3

4.2

—

Mixed conductive and sensorineural hearing loss

149

1161

1.29

2.37

4.3

3.5

—

Endometriosis

298

1456

1.20

2.37

2.8

3.3

—

Scleritis

2.30

2.36

2.3

5.0

—

Crohn disease (strict definition, all UC cases excluded)

259

1.63

2.36

1.9

3.7

—

Carcinoma in situ of skin of ear and external auricular canal

140

1.90

2.36

3.5

3.6

—

Chondrocostal junction syndrome [Tietze]

244

1.66

2.36

3.0

3.8

—

Voice disturbances

291

2439

1.20

2.35

3.5

3.4

—

Colorectal cancer

263

2135

1.21

2.35

2.4

1.5

—

Carbimazole or st.post thyroidectomy, condition for graves disease

196

1579

1.25

2.35

3.7

3.4

—

Alcohol withdrawal state with delirium

552

1.43

2.34

1.6

3.8

—

Focal epilepsy, strict definition

209

1697

1.24

2.33

2.6

3.4

—

Pain and other conditions associated with female genital organs and menstrual cycle

128

898

1.31

2.33

2.5

3.1

—

Malignant neoplasm of renal pelvis

3.04

2.31

2.3

1.2

—

Ocular pain

511

1.44

2.31

2.1

3.7

—

Pemphigoid

246

1.65

2.31

1.9

3.5

—

Alzheimer disease, including avohilmo

439

3560

0.86

2.31

2.7

3.2

—

Immunodeficiency associated with other major defects

4.84

2.31

1.0

4.4

—

Acute alcohol intoxication, ICD10

193

1556

1.25

2.30

2.3

3.6

—

Malignant neoplasm of testis

2.40

2.30

1.5

1.2

—

Benign neoplasm: Skin of trunk

285

1.60

2.29

5.8

4.0

—

Allergic urticaria

454

1.46

2.29

5.5

3.5

—

Other and unspecified iridocyclitis

293

1.58

2.29

3.5

3.8

—

Persistent mood disorders

183

1468

1.25

2.29

2.5

3.3

—

Malignant neoplasm of bronchus and lung, including Hilmo

253

1754

1.21

2.28

2.4

1.5

—

Crohn disease (strict definition, require KELA)

325

1.55

2.27

1.8

3.6

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

102

759

1.35

2.27

3.7

3.8

—

Dislocation, sprain and strain of joint and ligaments of hip

294

1.58

2.27

3.3

3.9

—

Allergic rhinitis

213

1718

1.23

2.27

3.2

—

Malignant neoplasm of head and neck

614

1.39

2.26

2.5

1.5

—

Other retinal artery occlusion

209

1.70

2.26

2.5

3.9

—

Disorders of adrenal gland, other and/or unspecified

3.21

2.26

1.1

4.8

—

D07AA Corticosteroids, weak (group I)

117

887

1.32

2.25

2.2

3.5

—

Additional codes for the location of defect, injury or illness

407

1.49

2.25

2.0

3.8

—

Restless leg syndrome

143

1117

1.29

2.25

2.0

3.5

—

Unspecified chronic bronchitis

287

1.58

2.24

1.5

3.8

—

Other acute viral hepatitis

2.37

2.24

3.1

3.3

—

Alopecia areata

135

1.87

2.23

4.6

3.6

—

Disorders of aromatic amino-acid metabolism

5.74

2.23

1.2

1.7

—

Persons encountering health services in circumstances related to reproduction

373

2923

0.86

2.23

3.5

3.3

—

Single delivery by caesarean section

421

0.65

2.23

2.5

2.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

197

1426

0.81

2.22

3.8

3.2

—

Sudden idiopathic hearing loss

116

883

1.32

2.22

3.3

3.6

—

Other and unspecified injuries of ankle and foot

202

1.70

2.22

1.4

3.8

—

Dacryoadenitis

2.57

2.21

1.6

5.0

—

Glucosamine medication

664

4733

1.12

2.21

3.4

—

Striking against or struck by other objects

297

2508

1.19

2.20

2.8

3.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

352

1.51

2.20

1.8

3.5

—

Certolizumab pegol

2.27

2.19

1.7

4.1

—

Other secondary gout

3.85

2.18

5.3

3.6

—

Chalazion

110

833

1.33

2.18

5.1

3.5

—

Other sideroblastic anaemias

3.82

2.18

2.1

4.2

—

Alcohol induced polyneuropathy

2.22

2.18

2.4

3.9

—

Malignant neoplasm of thymus, including Hilmo

3.81

2.18

1.3

1.0

—

Atypical virus infections of central nervous system

2.35

2.17

1.9

5.1

—

Other proliferative retinopathy

3.79

2.17

5.6

—

Mitochondrial myopathy

4.41

2.17

1.8

1.3

—

Other and unspecified nonscarring hair loss

3.07

2.17

1.2

5.5

—

Other and unspecified disorders of adult personality and behaviour

4.37

2.16

1.0

1.3

—

Achilles tendinitis

731

1.35

2.15

2.6

3.4

—

Superficial injury of wrist and hand

163

1301

1.26

2.15

2.8

3.3

—

Special screening examination for neoplasms

395

1.48

2.14

4.8

3.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

545

3814

1.13

2.14

3.2

3.4

—

Iridocyclitis in diseases classified elsewhere

123

1.90

2.13

1.3

4.3

—

Combined immunodeficiencies

2.25

2.13

5.9

5.0

—

Behavioural disorders, excluding more controls

2.79

2.13

1.4

4.1

—

Alzheimer’s disease (Early onset)

410

0.56

2.13

2.3

3.1

—

Abnormal findings in peritoneal fluid saliva

3.33

2.13

2.1

5.9

—

Nonalcoholic steatohepatitis

2.51

2.13

2.2

4.6

—

Contusion of ankle

197

1.69

2.13

2.1

3.6

—

Prepatellar bursitis

315

1.54

2.12

1.7

4.1

—

Other operation for atrial fibrillation

2.66

2.12

1.5

3.5

—

Benign neoplasm: Spinal meninges

2.18

2.11

1.6

5.2

—

Drug-induced fever

5.33

2.11

13.2

4.5

—

Vascular dementia (mixed)

168

1.76

2.11

1.8

3.4

—

Malignant neoplasm of corpus uteri

666

1.36

2.10

2.0

1.4

—

Polycystic ovarian syndrome

102

1.97

2.10

2.1

3.2

—

Infectious mononucleosis

244

1.60

2.09

4.8

2.9

—

Other and unspecified disorders of pigmentation

2.97

2.09

4.7

7.8

—

Pleural plaque with presence of asbestos

112

858

1.32

2.09

3.0

3.7

—

Osteosarcoma, including Hilmo

5.14

2.09

1.2

1.0

—

Allergic contact dermatitis due to drugs in contact with skin

146

1.81

2.08

2.0

4.3

—

Malignant cancer of tonsil and base of tongue, including Hilmo

146

1.80

2.08

5.6

1.3

—

Other enthesopathy of foot (+metatarsalgia)

684

1.35

2.08

2.9

3.7

—

All dysplastic lesions of the vagina

146

1.80

2.08

4.2

—

Juvenile osteochondrosis

124

1.87

2.07

3.2

3.5

—

Malignant neoplasm of parotid gland, including Hilmo

2.37

2.07

1.5

1.3

—

Other osteochondrodysplasias

2.36

2.06

1.9

4.6

—

Idiopathic peripheral autonomic neuropathy

4.14

2.06

6.2

3.5

—

Pilonidal cyst

390

1.47

2.06

2.9

3.3

—

Other mental disorders due to brain damage and dysfunction and to physical disease

153

1221

1.26

2.06

2.5

3.3

—

Tic disorders

3.53

2.06

8.4

6.0

—

Malignant neoplasm of testis, including Hilmo

2.20

2.05

1.5

1.2

—

Acute laryngitis and tracheitis

424

1.44

2.05

3.7

3.1

—

Ulcerative proctitis

350

1.50

2.05

3.2

3.9

—

Other injuries of lower limb, level unspecified

2.45

2.05

2.1

3.9

—

Melanocytic naevi of trunk

110

842

1.31

2.04

3.4

3.6

—

840

0.70

2.04

1.7

3.4

—

Carcinoma in situ of rectum

2.10

2.04

1.6

5.2

—

Diffuse brain injury

192

1.68

2.04

3.0

4.4

—

Malignant neoplasm of parotid gland

2.56

2.03

1.3

—

Other nonscarring hair loss

2.55

2.03

2.7

5.8

—

Malignant neoplasm of penis, including Hilmo

2.89

2.02

1.9

1.2

—

Malignant neoplasm of hypopharynx, including Hilmo

2.88

2.02

5.2

1.3

—

Childhood asthma (age<16)

168

1.64

2.02

3.2

1.6

—

Personal history of certain other diseases

2.52

2.02

1.4

5.4

—

Malignant melanoma

153

1224

1.26

2.01

5.2

1.5

—

Other disorders of binocular movement

1.98

2.01

3.7

4.0

—

Other otitis externa (chronic)

476

1.42

2.01

3.0

3.8

—

Somnolence, stupor and coma

320

1.51

1.99

2.2

3.9

—

Nontoxic goitre/thyroid nodule

338

2916

1.16

1.99

3.4

3.5

—

Thromboangiitis obliterans

3.46

1.99

1.0

3.7

—

Other predominantly sexually transmitted diseases, not elsewhere classified

113

871

1.30

1.99

3.0

3.2

—

Nezelof syndrome

3.44

1.99

1.1

5.8

—

Exposure to other and unspecified inanimate mechanical forces

460

1.42

1.99

2.1

3.6

—

Otitis media, unspecified

430

1.42

1.98

4.9

3.2

—

Unspecified severe protein-energy malnutrition

4.81

1.97

2.0

1.3

—

Drug-induced interstitial lung disorders, unspecified

4.80

1.97

6.8

6.2

—

Attention to artificial openings

305

1.52

1.97

3.4

3.6

—

Carcinoma in situ of lip, oral cavity and pharynx

3.93

1.97

12.0

3.9

—

Cystic fibrosis

4.74

1.96

1.2

1.9

—

Rheumatoid lung disease

2.83

1.96

1.2

5.9

—

Benign neoplasm: Lymph nodes

4.73

1.96

2.0

5.4

—

Malignant neoplasm of other and unspecified urinary organs

4.71

1.96

1.2

1.1

—

Abnormal reflex

3.05

1.96

1.3

5.0

—

Other or unspecified immunodeficiency

3.87

1.95

6.3

3.9

—

Alzheimer disease, excluding more controls

240

1323

1.20

1.95

3.2

4.0

—

Bus occupant injured in other and unspecified transport accidents

2.79

1.95

4.1

5.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

199

1644

1.22

1.95

1.8

1.5

—

Social phobias

257

1.56

1.94

3.3

3.5

—

Other and unspecified mononeuropathies of upper limb

195

1.66

1.94

3.8

4.1

—

Atypical facial pain

322

1.50

1.94

4.4

3.8

—

Secondary parkinsonism, excluding more controls

180

1.69

1.93

3.4

4.5

—

Chronic hepatitis NAS

2.09

1.93

1.1

4.5

—

Malignant neoplasm of corpus uteri, including Hilmo

101

772

1.32

1.92

2.0

1.4

—

Complications following infusion, transfusion and therapeutic injection

1.95

1.92

3.2

4.0

—

Magnesium deficiency

3.32

1.91

3.1

4.0

—

Dermatophytosis

658

5930

1.11

1.91

3.2

3.4

—

Fracture at wrist and hand level

329

2836

1.16

1.91

3.3

3.2

—

Lyme disease

235

2786

0.84

1.91

3.3

3.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.93

1.91

3.9

2.5

—

Unspecified organic or symptomatic mental disorder

3.29

1.90

6.1

5.2

—

Malignant neoplasm of accessory sinuses, including Hilmo

3.27

1.90

5.3

1.2

—

Ankle and foot

2.36

1.90

1.2

4.7

—

Calcific tendinitis of shoulder

373

1.46

1.90

3.7

3.9

—

Sequelae of other and unspecified effects of external causes

3.26

1.89

2.9

3.6

—

Melanoma in situ

407

1.44

1.89

6.2

3.9

—

Bullous pemphigoid

197

1.65

1.89

1.2

4.0

—

Macular hole

559

1.37

1.89

3.5

3.7

—

Pigmented purpuric dermatosis

2.13

1.89

2.7

5.9

—

Drug-induced gout

2.95

1.89

2.3

2.8

—

Dystonia

357

1.47

1.89

1.9

4.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

180

1477

1.22

1.88

3.8

3.5

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

2.93

1.88

1.1

2.3

—

Symptoms and signs involving emotional state

151

1.74

1.88

2.2

4.0

—

Propionic acid derivatives

327

1411

1.17

1.88

3.3

3.1

—

Clubfoot

2.69

1.87

2.2

4.7

—

Arthropathy in Crohn disease

2.43

1.87

1.2

4.9

—

Anorexia (incl.atypical)

236

1.57

1.87

3.0

3.4

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

159

1.71

1.86

5.1

4.0

—

Hordeolum and other deep inflammation of eyelid

358

1.46

1.86

3.3

3.7

—

Alzheimer disease

381

3183

0.87

1.86

2.8

3.1

—

Sequelae of injuries of lower limb

620

1.35

1.86

3.0

3.5

—

Other cranial nerve disorders in other disorders

4.33

1.84

5.0

5.7

—

Dislocation, sprain and strain of joints and ligaments at neck level

109

847

1.29

1.84

3.2

3.6

—

Degenerative macular diseases

157

1276

1.24

1.83

2.5

3.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

325

2444

1.16

1.83

3.0

3.5

—

Arthropathy in ulcerative colitis

2.15

1.83

1.6

4.5

—

Idiopathic hypoparathyroidism

3.18

1.83

1.1

3.3

—

Hypertrophy of breast in women and men

161

1311

1.23

1.83

2.5

3.2

—

Panniculitis affecting regions of neck and back

222

1.59

1.83

2.9

3.4

—

Meretoja disease

3.16

1.83

6.1

2.6

—

Premature rupture of membranes

558

0.70

1.82

3.0

3.4

—

Dissociative [conversion] disorders

160

1.70

1.82

2.7

3.8

—

Vitamin A deficiency

3.13

1.82

1.0

7.0

—

Malignant neoplasm of rectosigmoid junction

1.94

1.82

1.9

1.3

—

Other disorders of amino-acid metabolism

3.13

1.82

6.7

2.3

—

Other and unspecified neuropathies

2.85

1.82

1.3

3.8

—

Other disorders of carbohydrate metabolism

3.13

1.82

1.0

3.5

—

Other and unspecified glaucoma

675

1.33

1.82

2.2

3.2

—

Injury of other and unspecified intrathoracic organs

503

1.38

1.81

2.8

3.4

—

Wilms' tumor, including Hilmo

3.11

1.81

2.4

1.3

—

Right hemicolectomy

555

1.36

1.81

2.0

3.5

—

Speech and linguistic disorders

259

1.52

1.80

2.2

3.4

—

Tic and related disorders

3.07

1.80

8.4

5.3

—

Symptoms and signs involving appearance and behaviour

2.80

1.80

1.1

6.1

—

Melanocytic naevi of lower limb, including hip

263

1.53

1.79

4.6

3.9

—

Spirochaetal infections, other/unspecified

238

2801

0.85

1.79

3.3

3.4

—

Melanocytic naevi, other sites/unspecified

538

1.36

1.79

4.0

3.6

—

Spasmodic torticollis

192

1.63

1.79

2.1

4.2

—

Carcinoma in situ of skin, other sites/unspecified

124

1.81

1.79

3.7

4.0

—

Other drug-induced secondary parkinsonism

2.07

1.78

2.3

4.0

—

Maternal care for other known or suspected fetal problems

440

0.69

1.77

2.2

3.2

—

Hereditary nephropathy, not elsewhere classified

3.48

1.77

6.3

6.6

—

Ectopic pregnancy

1058

0.75

1.76

3.6

3.5

—

Other/unspecified enthesopathies, not elsewhere classified

643

1.33

1.76

3.0

3.7

—

Other and unspecified paralytic syndromes

2.06

1.76

4.7

4.4

—

Hypersensitivity pneumonitis due to organic dust

117

1.82

1.76

2.6

4.3

—

Secondary malignant neoplasm of other and unspecified sites

117

1.82

1.76

1.2

—

Chronic constrictive pericarditis

3.07

1.76

1.9

5.2

—

Disorders of vestibular function (Vertigo)

565

5001

1.11

1.76

3.5

3.3

—

Pollen allergy

729

1.30

1.75

3.6

3.3

—

Other spirochaetal diseases

239

2805

0.85

1.75

3.3

3.4

—

Malignant neoplasm of breast, ER-positive, including Hilmo

287

1903

1.17

1.75

3.3

1.5

—

Apocrine sweat disorders, other sweat gland disorders

3.01

1.74

16.1

6.4

—

Fracture of spine, level unspecified

4.03

1.74

5.0

6.5

—

Implicit parasitic Sepsis

2.99

1.74

4.0

5.8

—

Disorder of mineral metabolism, other/unspecified

4.02

1.74

7.4

1.1

—

Follicular lymphoma, hilmo

381

1.43

1.74

2.4

4.0

—

Pyoderma

125

1.78

1.73

3.5

3.9

—

Other disorders of the genitourinary system

143

1159

1.24

1.73

3.1

3.4

—

Lumbosacral plexus disorders

3.96

1.73

1.2

1.6

—

Labyrinthitis

3.96

1.73

4.8

3.5

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.16

1.73

2.6

4.8

—

Other spirochaetal diseases

242

2834

0.85

1.73

3.3

3.4

—

Hereditary sideroblastic anaemia

3.95

1.73

2.6

6.5

—

Unspecified mental disorder

362

3175

1.14

1.73

2.6

3.3

—

Cluster headache, wide,, including avohilmo

274

1.51

1.72

1.3

3.8

—

Malignant neoplasm of tonsil

1.94

1.72

2.9

1.3

—

Normotensive glaucoma

113

893

1.27

1.72

2.6

3.2

—

Schizophrenia or delusion

270

2321

1.17

1.71

2.7

3.2

—

Herpesviral keratitis and keratoconjunctivitis

299

1.48

1.71

3.8

—

Algoneurodystrophy

148

1.70

1.71

1.4

4.0

—

Urethral stricture

561

1.35

1.70

2.1

3.8

—

Malignant neoplasm of colon

162

1333

1.22

1.70

2.4

1.5

—

Unspecified urinary incontinence

735

1.30

1.70

2.1

3.3

—

Short Achilles tendon (acquired)

164

1.66

1.69

2.0

4.3

—

Pneumoconiosis due to other inorganic dusts

3.25

1.68

1.2

4.2

—

Disturbance of activity and attention

222

1.55

1.68

1.4

2.0

—

Acquired keratosis [keratoderma] palmaris et plantaris

2.88

1.67

2.9

5.4

—

Other congenital malformations, not elsewhere classified

3.20

1.67

1.5

4.4

—

Appendicitis, broad definition

758

6275

1.09

1.66

3.3

3.4

—

Diseases of appendix

766

6322

1.09

1.66

3.3

3.4

—

Tetraplegia

2.49

1.66

1.5

2.8

—

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

2.49

1.66

2.0

1.4

—

Follow-up care involving plastic surgery

204

1.58

1.66

5.6

3.6

—

LSIL lesion of the cervix uteri, vagina or vulva

632

1.32

1.66

4.0

3.4

—

Plantar fascial fibromatosis

659

1.31

1.65

2.7

3.7

—

Other disorders of binocular vision

2.47

1.65

11.0

4.6

—

Miliary tuberculosis

3.78

1.64

2.2

2.1

—

Behavioural disorders

2.45

1.64

1.4

3.4

—

Kela-code for severe mental illness

330

2889

1.14

1.64

2.4

3.3

—

Superficial injuries involving multiple body regions

150

1.68

1.64

6.3

4.4

—

Cicatricial pemphigoid

3.75

1.64

1.0

10.4

—

Schizoaffective disorder

410

1.40

1.64

1.6

3.8

—

Nontoxic single thyroid nodule

530

1.35

1.64

2.8

3.2

—

Prolonged pregnancy

386

0.63

1.63

4.3

3.3

—

Injury of muscle and tendon at hip and thigh level

704

1.30

1.63

2.4

3.6

—

Secondary sideroblastic anaemia

3.69

1.63

3.0

7.6

—

Juvenile cataract

3.65

1.63

2.2

1.4

—

Postprocedural disorders of nervous system

294

1.47

1.62

3.5

3.4

—

Hypertensive encephalopathy

2.59

1.62

1.4

5.8

—

Traumatic subarachnoid haemorrhage

270

1.49

1.62

3.7

4.2

—

Torsion of testis

2.16

1.61

4.3

3.2

—

Focal brain injury

471

1.37

1.61

3.7

3.9

—

Meckel's diverticulum

2.55

1.61

1.5

3.2

—

Hyperkinetic disorders

240

1.51

1.61

1.4

2.2

—

Melanoma in situ of scalp and neck

3.14

1.61

12.2

5.5

—

Volvulus

206

1.57

1.61

2.5

3.5

—

Alcohol dependence

293

2550

1.15

1.60

1.9

3.5

—

Abnormal findings in cerebrospinal fluid

3.11

1.60

2.0

5.9

—

Acute mastoiditis

2.36

1.60

4.3

5.0

—

Implicit parasitic Sepsis

2.75

1.59

4.0

5.6

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

167

1.63

1.59

1.7

3.9

—

Polymorphous light eruption

2.73

1.59

2.3

3.3

—

Postmenopausal bleeding

298

1378

1.16

1.59

3.3

3.4

—

Narcolepsy and cataplexy

3.04

1.59

3.5

2.1

—

Malignant neoplasm of oropharynx

1.84

1.59

3.8

1.3

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Immunoglobulin light chains.free panel - Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS